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1. Introduction 
The antibiotic resistance evoked by harmful bacterial strains, have seen a firm upsurge over a 
period of time even since the introduction of penicillin by Alexander Fleming in 1940.(1-5) The 
immunity of the microorganism towards host antigens and external antibiotics is facilitated by 
the strength of the bacterial envelope.(6-9) (Fig.1). The bacterial envelope of gram negative 
bacteria consists of Lipopolysaccharides which gives stability and antibiotic resistance to the 
bacterium. (10-12). To circumvent the increased drug resistance of the bacteria the structural 
components of lipopolysaccharides are used in drugs (glycoconjucate vaccines). So the 
isolation, structural elucidation and synthesis of these potential drug candidates are the area of 
prime focus in the chemistry and biochemistry of carbohydrates.(14-20)  
 
 
 
Figure 1. Bacterial envelope (a) Gram positive (b) Gram negative(21) (c) Mycobacteria 
 
Lipopolysaccharides are present exclusively in the cell wall of Gram negative bacteria. (Fig. 1 
shows the bacterial envelope of three major types of bacteria) It consists of Lipid A and layers 
of polysaccharides. Lipid A is composed of β-linked glucosamine disaccharides that are 
substituted with long chain fatty acids and phosphate groups.(22) The polysaccharides consists 
of core regions (inner and outer core containing various sugar residues) and O-chain or O-
polysaccharide (See Fig 2). The outer most part of Lipopolysaccharides is the O-chain or O-
polysaccharide which is also called as O-antigen due to its vulnerability to attack from host 
antibodies and external antibiotics.(23) Due to its proximity to hostile surroundings, the O-
antigens evolve with limitless diversity in structure, composition and linkage of the 
constituent glycosyl residues. There are over 160 different strains of O-antigen structures 
produced by E.coli.(24) The surface of some bacterial envelope is associated with an S-layer 
(Surface layer) compromising of glycoprotein. The S-layers are associated to the 
lipopolysaccharides via ionic, carbohydrate–carbohydrate, protein–carbohydrate interactions 
and/or protein–protein interactions. These functional characteristics make the 
lipopolysaccharides as a lethal component of gram negative bacteria.  
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Figure 2. Lipopolysaccharides in bacterial cell wall(25) 
 
Characterisation of highly complex molecules such as Lipopolysaccharides was possible due 
to various advancements in analytical techniques such as nuclear magnetic resonance (NMR) 
and mass spectroscopy (MS) methods.(26) The complete structure of LPS in B. pertussis strain 
1414 (Fig. 3)(17,28,29) was determined by matrix-assisted laser desorption ionization mass 
spectrometry (MALDI) while the absolute configuration of the vaccine component in Band A 
trisaccharide was characterised by NMR NOE experiments. Characterisation of various 
strains of bacterial lipopolysaccharides has been reported and still many more are done.(30-34) 
Characterisation of absolute configuration of units present in bacteria such as Pseudomonas 
aeruginosa,(35,36) Bordetella parapertussis(37) and Bordetella pertussis has shown a presence of 
general class of 2,3-acetamido uronic acids which has motivated us to attempt a synthetic 
process for the same.   
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Figure 3. Complete structure LPS of B.pertussis (Band A trisaccharide coloured in green)  
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Synthesis of these LPS fragments forms an important part of the pharmacology of the 
antibiotics.(38,19,20) Synthesized LPS fragments could be used as a component of vaccine, to 
understand the mechanism of enzymatic synthesis and structural elucidation of natural 
products.(39,40) Challenges faced in such multi step synthesis are huge which can be simplified 
by identifying an array of sugars and synthesising it with a common strategy. So the 
identification of several sugars with the presence of 2,3-diacetamido uronate patterns has 
motivated us to devise a common strategy for its synthesis. So, current efforts are directed 
towards the synthesis of these uronic acid derivatives (Fig. 4), which can be used as glycosyl 
donors and acceptors in glycosylation reaction to produce oligosaccharides. 
 
OO
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OCH3
O
O
R2R1 O
O
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OCH3
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O
R2
R1
OO
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O
OCH3O
R2
R1
a b c  
Figure 4. (a) gluco- (b) galacto- (c) manno-configurated 2,3-diacetamido uronates 
 
These oligosaccharides can play an important role in the pharmacology of antibiotics against 
drug resistant gram-negative bacterial strains. Therefore, the following objectives were 
defined for my practical work of my thesis: 
Objectives  
• Improved synthesis of methyl 2,3-diacetamido-2,3-dideoxy-D-glucuronate starting 
from D-glucosamine 
• Improved synthesis of methyl 2,3-diacetamido-2,3-dideoxy-D-galacturonate starting 
from D-glucosamine 
• Improved synthesis of methyl 2,3-diacetamido-2,3-dideoxy-D-mannuronate via 
epoxide intermediates 
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2. Results and Discussion 
2.1 Improved Synthesis of Methyl 2,3-diacetamido-2,3-dideoxy-D- 
glucuronate (28) 
2.1.1  Synthesis of 2,3-diacetamido-2,3-dideoxy-D-glucopyranoside (11) 
Procedures described in the literature  
The simplest methodology described in the literature to get methyl 2,3-diaceamido-2,3-
dideoxy-D-glucuronate  used benzyl 2,3-diacetamido-2,3-dideoxy-α-D-glucopyranoside as an 
intermediate which was then oxidised to obtain the desired uronates. The preparation of 2,3-
diacetamido glucopyranoside 11 was reported by Wolfgang Meyer zu Reckendorf.(41,42)  
The key step is the double inversion at C-3 position including introduction of an azido group 
in equatorial position. After reduction the resulting amino function was acetylated to provide 
the desired benzyl 2,3-diacetamido-2,3-dideoxy-α-D-glucopyranoside. Similar strategies were 
employed by R.A.Field et al(40) and A. A. Nazarov, B. K. Keppler, et al(43) for the preparation 
of the pyranoside 11.  
Proven method and their optimization   
 
OHO
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32
a b
 
Scheme 1. Protection groups: (a) BnOH, HCl, 55 °C (b) PhCH(OCH3)2, 35 °C, 55%. 
 
Classical Fischer glycosylation of N-acetylglucosamine (1) using anhydrous HCl as catalyst 
(obtained by adding AcCl to dry BnOH) in BnOH at 55 °C provided the benzyl glycoside 2 
which was used without isolation in the next step. Introduction of benzylidene group at the 
4,6-O-position was carried out by addition of benzaldehyde dimethyl acetal to the reaction 
mixture. After stirring overnight at 35 °C, derivative 3 was isolated in 55% yield. Purification 
was done by repeated crystallization from pyridine/water and EtOH. Importantly, the N-acetyl 
glucosamine should be well powdered and dried (80 °C for 4 h) before use. 
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Scheme 2. Double inversion at C-3 position: (a) MsCl, pyridine, 0 °C, 82% (b) H2O, 
CH3COONa, ethylene glycol monomethyl ether, reflux, 78% (c) NaN3, TBAHS, DMF, 
120°C, 65% (2 steps). 
 
Transformation of the equatorial hydroxyl group at C-3 position of compound 3 in to 
an azido group at the same position and with the same configuration (compound 7) was 
carried out by double inversion. First, mesylation with methanesulfonyl chloride in pyridine at 
0 ºC provided compound 4 in 82% yield.(43) Second, nucleophilic substitution of the mesyl 
group by aq sodium acetate in ethylene glycolmonomethyl ether under reflux resulted in an 
inversion of configuration at the C-3 position to provide the allo-configurated sugar 5 in 78% 
yield. After renewed mesylation of the hydroxyl group at C-3 position, the substitution of the 
mesyl group by NaN3 in the presence of tertrabutylammonium hydrogen sulfate (TBAHS) in 
DMF at 120 ºC resulted in inversion of configuration at C-3 position providing gluco-
configurated compound 7 in 65% yield (2 steps).(43) When the reaction was carried out in the 
absence of TBAHS, incomplete conversion of the starting material was observed even at 
reflux temperatures.  
 
O
MsO
AcHN
O
O
Ph
OBn
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H
H H
4 6
3J3,4= 9.2 Hz 3J3,4 = 2.8 Hz  
Figure 5. 1H NMR: Comparison of coupling constants at positions 3 and 4 of compounds 
4 and 6. 
 
The change of configuration in the case of sugars 4 and 6 (Fig 5.) were evident by 1H 
NMR coupling constants. The proton at C-3 position of compound 4 showed a trans-axial 
coupling constant of 3J3,4= 9.2 Hz while the allose isomer 6 coupled at a lower frequency of 
3J3,4 = 2.8 Hz due to less intense cis-coupling. 
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Scheme 3. Preparation of benzyl 2,3-diacetamido-2,3-dideoxy-α-D-glucopyranoside:           
(a) H2O, CH3COOH, 80 °C, 79% (b) Pd/C, H2, CH3OH (c) Ac2O, pyridine (d) CH3ONa (0.5 
M), CH3OH, 55% (4 steps). 
 
Cleavage of the benzylidene group of 7 was carried out by using 80% aqueous acetic acid at 
90 °C to get the deprotected sugar 8 with free hydroxyl groups at 4 and 6 positions.(43) 
Furthermore, the azido group of compound 8 was converted into an acetamido group in three 
steps. First, the reduction of the azido group of compound 8 to an amino group (compound 9) 
was done by catalytic hydrogenation using Pd (10% on activated charcoal) in methanol under 
an atmosphere of H2.(43) Second, crude product 9 was directly used for consecutive acetylation 
with Ac2O and pyridine providing complete acetylated product 10. Finally, selective de-
acetylation of the O-acetyl groups using 0.5 M CH3ONa in methanol gave the diacetamido 
glucose derivative 11 in overall yield of 55% yield (over 4 steps, from compound 7). 
2.1.2 Synthesis of methyl 2,3-diacetamido-2,3-dideoxy-4-benzoyl-D-glucuronate  
Methyl 2,3-diacetamido-2,3-dideoxy-D-glucuronate was prepared by oxidation of  benzyl 2,3-
diacetamido-2,3-dideoxy-α-D-glucopyranoside.  
Procedures described in the literature 
Oxidation of nucleic acid derivative of 2,3-diacetamido-2,3-dideoxy-glucopyranoside (see 
Fig. 6) by PtO2 (prepared from high surface platinum and molecular O2) was reported by 
Martin Rejzek et al.(40) Oxidation using TEMPO and several secondary oxidants was reported 
too.(44-52) An excellent composition of recent advances in TEMPO oxidation was compiled by 
Félix Calderón.(53)  
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Figure 6. Martin Rejzek et al: Preparation of diacetamidoglucuronic acid. 
 
Proven methods and their optimization   
OHO
AcHN
AcHN
OH
11
OBn
OHO
AcHN
AcHN
OBn
OH
O
not isolated
OR
AcHN
AcHN
OBn
OMe
O
13R = OH
14 R = OBz
a b
c12
 
Scheme 4. Oxidation of benzyl 2,3-diacetamido-2,3-dideoxy-α-D-glucopyranoside: (a) 
TEMPO, BAIB, H2O, DCM (b) CH2N2, CH3OH, 68% (2steps)  (c) BzCl, Pyridine, DCM, - 5 
°C, 67%. 
  
Selective oxidation of the primary hydroxyl group of pyranoside 11 in the presence of a 
secondary hydroxyl group was carried out by using catalytic amount of TEMPO (2,2,6,6-
tetramethylpiperidine-1-oxyl) radical (primary oxidant) and stochiometric amount of BAIB 
(bis(acetoxy)iodobenzene; secondary oxidant). Importantly, TLC strictly controlled the 
duration of the reaction because the reaction gives lower yields if prolonged for longer than 
the time of complete conversion of the starting material. Also, the duration of the reaction has 
to be optimized depending on the scale of the reaction. Treatment of crude carboxylic acid 
product 12 with diazomethane in methanol resulted in methyl ester 13 in 68% yield. 
Subsequent benzoylation was carried out with BzCl in pyridine at -10 °C to produce 14 in 
67% yield.  
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Scheme 5. Mechanism of TEMPO/BAIB oxidation 
    
Various secondary oxidants for the TEMPO oxidation were tried. The NaOCl-KBr oxidant 
gave no conversion of the starting material controlled by TLC, while complete conversion is 
attained in case of the CaOCl2 variant, but the yield of the reaction was only 25%.  
2.1.3 Improvements in oxidation reactions  
Even though oxidation of 2,3-diacetamido-D-glucopyranoside 11 was successful, the reaction 
gave lower yields when it was upscaled to 500 mg scale. So, as a modification to the present 
scheme, instead of using the diacetamido compound 11 as a starting material, compound 8 
carrying an azido group instead of the acetamido group in the C-3 position was used. 
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Scheme 6. (a) TEMPO, BAIB, DCM, H2O (b) CH2N2, CH3OH 79% (2 steps) (c) BzCl, Pyridine, 
DCM, –5 °C, 89% (d) Pd/C, H2, Ac2O, MeOH (e) Pd/C, H2, AcCl, MeOH, 90%.  (2 steps). 
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Surprisingly, TEMPO/BAIB oxidation of compound 8 proceeded with excellent improvement 
in yield and scalability of the reaction. Compound 15, which was obtained as a crude product 
after the oxidation reaction underwent esterification with diazomethane in methanol resulting 
in compound 16 at 79% yield. The remarkable improvement in the yield from 68% to 79% 
was achieved when the reaction was done in scale of 1g. Similar to the oxidation of 2,3-
diacetamidoglucopyranoside (11, Sec 2.1.2), the duration of the reaction was strictly 
controlled by TLC to avoid the formation of side products after complete conversion of the 
starting material. Furthermore, the step of benzoylation showed an additional improvement of 
yield from 67% to 89% to get compound 17. The benzoylation reaction which was definitely 
influenced by the presence of an azido group instead of an acetamido group at C-3 position 
was carried out using BzCl in pyridine/DCM mixture at –5 ºC. Next, the conversion of the 
azido group in to acetamido group at C-3 position and the reductive cleavage of the benzyl 
group at the anomeric position of compound 17 were carried out as a one pot reaction. First, 
the conversion of the azido group in to acetamido group was carried out by using Pd (on 
activated charcoal) in a mixture of Ac2O and abs. methanol under an atmosphere of H2. After 
completion of the reaction, small amount of AcCl was directly added to the crude product 14 
and stirred under an atmosphere of H2 effects the reductive cleavage of the benzyl protection 
group. The three step one pot reaction produced compound 18 in an excellent yield of 90%.   
2.1.4 Summary 
With respect to the methods reported in literature, several changes were made to the 
processes, which resulted in increased yield and scalability of the reactions. Preparation of 
compound 3 was done using two step one pot reaction in comparison to the two separate 
reactions reported in the literature.(40,43) Oxidation of the pyranosides to uronates was done 
using TEMPO/BAIB reagents instead of PtO2/molecular O2 method reported in the literature.  
On the contrary to the literature report, the TEMPO oxidation of the primary hydroxyl group 
was found to undergo selectively with out any over oxidation of the secondary hydroxyl 
group at C-4 position.(54) Finally, the improvements made in the synthetic strategy by 
performing the oxidation reaction prior to the conversion of the azido group in to acetamido 
group resulted not only in remarkable improvement in the yield and scalability of the 
oxidation reaction but also of the subsequent steps of benzoylation and reduction reactions. 
The reduction of azido group in to amino group, conversion of the amino group in the 
acetamido group and reductive cleavage of anomeric benzyl protection group was carried out 
as one pot reaction with excellent yield and scalability.  
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2.2  Improved synthesis of Methyl 2,3-diacetamido-2,3-dideoxy-D- 
galacturonate (18) 
2.2.1 Synthesis of 2,3-diacetamido-2,3-dideoxy-D-galactopyranoside  
Procedures described in the literature  
Benzyl 2,3-diacetamido-2,3-dideoxy-D-galactopyranoside was prepared from its glucose 
isomer (benzyl 2,3-diacetamido-2,3-dideoxy-D-glucopyranoside), by inversion of 
configuration of hydroxyl group at C-4 position (from equatorial to axial position). The 
method was also reported by Wolfgang Meyer Zu Reckendorf in 1970.(55)  
Proven methods and their optimization   
OMsO
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AcHN
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OBn
19
O
HO
AcHN
AcHN
OH
OBn
20
OMsO
AcN
AcHN
OBn
21
+
a bOHO
AcHN
AcHN
OH
11
OBn
 
Scheme 7. Inversion of configuration at C-4. (a) MsCl, pyridine, 0 °C, 79% (b) H2O, 
CH3COONa, ethylene glycol monomethyl ether, reflux, 65%. 
 
As mentioned above, the conversion of the glucose isomer to galactose isomer was achieved 
by inversion of configuration of the hydroxyl group at C-4 position. For this reason both 
hydroxyl groups of compound 11 (at C-4 and C-6 positions) were converted in to mesyl 
groups using MsCl in pyridine at 0 °C to provide the dimesyl compound 19 in 79% yield. The 
following nucleophilic substitutions at C-4 and C-6 positions was carried out by using 
CH3COONa in ethylene glycol mono methyl ether and water under reflux to get the galactose 
derivative 20 in 65% yield. Intramolecular substitution of the mesylate at C-6 position by the 
acetamido group at C-4 position produced the bicyclic side product 21 in 15% yield.(55)   
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Figure 7. 1H NMR coupling constants: Comparison of coupling constants at positions 3 and 4 
of compounds 11 and 20. 
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The change of configuration from compound 11 to galacto-configurated 20 (Fig 7.) 
was evident by 1H NMR coupling constants. The proton at C-4 position of glucose compound 
11 showed a trans-axial coupling constant of 3J3,4= 9.5 Hz while the galactose isomer 20 
coupled at a lower frequency of 3J3,4 = 2.5 Hz due to less intense cis-coupling.  
2.2.2 Synthesis of methyl 2,3-diacetamido-2,3-dideoxy-D-galacturonate 
Similar to the preparation of methyl-2,3-diacetamido-2,3-dideoxy-D-glucuronate 13, methyl-
2,3-diacetamido-2,3-dideoxy-D-galacturonate was prepared by oxidation of  benzyl 2,3-
diacetamido-2,3-dideoxy-α-D-galactopyranoside 20.  
Procedures described in the literature Selective	  oxidation	  of	  primary	  hydroxyl	  group	  of	  galactose	  which	  was	  was	  connected	  with	  a	  rhamnopyranoside	  to	  form	  a	  disaccharide	  (Fig	  8),	  was	  reported	  by	  R.A.Field	  et	  al.(56)	  The	  oxidation	  was	  carried	  out	  by	  using	  TEMPO-NaOCl system in 73% yield.  
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Scheme 8. (a) Oxidation of plant cell wall disacharides: TEMPO, NaOCl, KBr, H2O, 73%. 
 
 Furthermore, G.A.Van der Marel et al reported the oxidation of the primary hydroxyl group 
of a galactose thioglycoside with TEMPO-BAIB sytem.(46,47) Interestingly, the primary 
alcohol is first oxidised to a lactone, which on stirring with methanol undergoes 
transesterification to produce the required uronate.  
 
 
Scheme 9. Oxidation and lactone formation: (a) TEMPO, BAIB, H2O, DCM, (b) CH3OH, 
75% (2 steps). 
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Scheme 10. (a) TEMPO, BAIB, H2O, DCM, (b) CH2N2, CH3OH, 68% (2 steps) (n) BzCl, 
pyridine, DCM, –5 °C, 62% 
 
Proven methods and their optimization   
The transformation of the galacto-configurated pyranoside 20 to uronic acid 22 was achieved 
by selective oxidation of the primary hydroxyl group in the presence of a secondary hydroxyl 
group using catalytic amount of TEMPO radical (primary oxidant) and stochiometric amount 
of BAIB (secondary oxidant). Importantly, the duration of the reaction was strictly controlled 
by TLC, because the reaction gives lower yields if prolonged for longer than the time of 
complete conversion of the starting material. Also, the duration of the reaction has to be 
optimized depending on the scale of the reaction. Treatment of the crude carboxylic acid 
product 22 with diazomethane in methanol resulted in the methyl ester 23 in 68% yield. In 
comparison to the oxidation reaction of the glucose isomer 11, the reaction of galactose 
isomer takes longer time, subjectively due to the steric effects produced by the axially 
configurated C-4 hydroxyl group. Oxidation with TEMPO and NaOCl did not result in 
conversion of the starting material. Subsequent benzoylation with BzCl in pyridine at –10 °C 
produced compound 24 in 62% yield. In comparison, the same reaction with the glucose 
isomer resulted in a slightly better yield of 68%.  
2.2.3 Improvements in the synthesis of methyl 2,3-diacetamido-2,3-dideoxy-D-
galacturonate  
Similar to 2,3-diacetamido-2,3-dideoxy-glucopyranoside, upscaling of the oxidation 
procedure applied to 2,3-diacetamido-2,3-dideoxy-galactopyranoside leads to decreased 
yields. 
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Scheme 11. (a) Tf2O, pyridine, DCM, –10 °C (b) NaNO2, DMF 69% (2 steps) (c) BzCl, pyridine, 
DCM, –5 °C 89% (d) Pd/C, H2, Ac2O, MeOH (e) Pd/C, H2, AcCl, MeOH, 87%.      (2 steps) 
 
Therefore, methyl(benzyl 2-acetamido-3-azido-2,3-dideoxy-α-D-glucopyranoside)uronate 16 
obtained by a  improved oxidation procedure (Sec. 2.1.3 Improvements of oxidation 
reactions) was used as starting material for the preparation of methyl 2,3-diacetamido-2,3-
dideoxy-D-galacturonate. In order to convert glucuronate 16 into the corresponding 
galacturonate 26 triflate intermediate 25 was prepared by using triflic anhydride, pyridine in 
DCM at –10 °C which was then used without further purification for the next step. Treatment 
of 25 with NaNO2 in DMF gave after 48 hours compound 26 in 78% yield (over 2 steps). 
Benzoylation of galacturonate 26 with BzCl in pyridine and DCM at –5 °C resulted in 
compound 27 in 89% yield. Similar to the glucose isomer, benzoylation of the 3-azido 
derivative 26 compared to the corresponding 3-acetamido derivative 23 leads to improved 
yields (62% to 89%). Next, the conversion of the azido group in to acetamido group at C-3 
position and the reductive cleavage of the benzyl group at the anomeric position of compound 
27 were carried out as described for glucuronate 18. The three step one pot reaction produced 
compound 28 in an excellent 87% yield.  
16
OHO
N3
AcHN
OCH3
OBn
O
O
BzO
N3
AcHN
OCH3
OBn
O
O
N3
AcHN
OCH3
OBn
O
+
27 29
a
 
Scheme 12. Mitsunobu esterification (a) Diisopropyl azodicarboxylate, benzoic acid, PPh3, 
DMF 
To reduce synthetic steps, direct benzoylation with inversion of configuration at C-4 under 
Mitsunobu reaction conditions was proved on compound 16. Unfortunately, the major product 
of the reaction was compound 29 as result of elimination. The desired product 27 was 
obtained in minor amount.  
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Figure 8. 1H NMR coupling constants: Comparison of coupling constants at positions 3 and 4 
of compounds 17 and 27.  
 
As in previous case, the change in configuration at C-4 position was confirmed by the NMR 
coupling constants (Figure 8). The glucose isomer 17 gave a trans-axial coupling constant of 
3J3,4= 9.6 Hz while the galactose isomer 27 coupled with a lower frequency of 3J3,4 = 2.8 Hz 
due to less intense cis-coupling.   
2.3 Improved synthesis of Methyl 2,3-diazido-4-benzoyl-2,3-dideoxy-D-
mannouronate 
 
2.3.1 Synthesis of phenyl 2,3-diacetamido-2,3-dideoxy-mannopyranoside  
Procedures described in the literature  
For the preparation of phenyl 2,3-diacetamido-2,3-dideoxy mannopyranoside the key 
intermediate is the epoxide phenyl 2,3-anhydro-4,6-O-benzylidene-β-D-allopyranoside. 
Several variations has been reported in the literature to get epoxides by using basic hydrolysis 
(aq.KOH) or methanolysis (NaOMe) of disulfonate sugars (mesyl or tosyl) over a range of  
temperatures from RT to 80 ºC.(57-59) However, the preparation of epoxide directly from the 
sugar diols using Mitsunobu reagent was found to be better than all the other reported 
methods.(60-65) Furthermore,  T. Norberg et al. described the synthesis and ring opening of 
epoxides by substitution reactions that facilitates the formation of 2,3-diazido manno 
pyranoside.(66) As shown before, several methods are available in the literature for the 
conversion of the azido group to acetamido group and cleavage of benzylidene protection 
group to produce the required 2,3-diacetamido-2,3-dideoxy mannopyranoside.(40,43) 
Proven methods and their optimization   
As reported in the literature, various methods were attempted for the preparation of epoxide 
sugars.  
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Scheme 13. Formation of epoxides (a) MsCl, pyridine, 0 °C, 84% (b) CH3ONa(0.5 M), 
CH3OH/THF, reflux, 45% (c) dialkyl azodicarboxylate, PPh3, DMF, 80 °C, 77%. 
 
Initially, a couple of methods for the preparation of epoxide from the dimesyl compound 31 
were tried. The reactions proceeded through in situ nucleophile generation (at the C-2 
position) and a substitution reaction (at the C-3 position), generating the epoxide at the 2,3 
position. The reactions were performed using either 30% aq KOH solution or methanolic 
CH3ONa (0.5 M) in CH3OH/THF (1:1 v/v) under reflux conditions. However, both reactions 
resulted in poor yields with the generation of unwanted isomeric mannose epoxide 33 (Fig 9).  
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Figure 9. Structure of phenyl 2,3-anhydro-4,6-O-benzyliden-β-D-mannopyranoside 
 
 
Scheme 14. Mechanism of epoxide formation(67) (a) Dialkyl azodicarboxylate, PPh3, DMF. 
Finally, epoxide 32 was prepared directly from diol 30 by Mitsunobu reaction using PPh3 and 
dialkyl azodicarboxylate (i-propyl, t-butyl or ethyl) at 80°C in dry DMF. After completion of 
the reaction, direct evaporation of the reaction mass followed by simple crystallisation of the 
syrupy crude residue in ethanol resulted in the crystalline epoxide product 32 in 77% yield 
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(using DIAD, diisopropyl diazocarboxylate).(68) Using the above process, reactions up to 20 g 
scale were performed without any trouble. Nevertheless, due to the explosive nature of 
azocarboxylates,(69) an alternative procedure was developed using the t-butyl variant (DBAD) 
of the azocarboxylate. After the reaction, a simple work-up decomposes the explosive 
azocarboxylate (DBAD) in to safer byproducts.(70,71) Preliminary reactions with DEAD (ethyl 
azodicarboxylate, 40% in toluene) proceeded with a moderate yield of 65%, but considering 
the hazardous nature of DEAD, further optimisation of the reaction conditions was not carried 
out. The ideal solvent for the reaction was found out to be DMF, after obtaining negative 
results with DCM and 1,4-dioxane. Initially the purification of the crude reaction mass was 
tried with column chromatography, but due to the presence of a high amount of PPh3, the 
separation of the product from PPh3 was not possible. However, this problem could be averted 
by the conversion of PPh3 to polar PPh3O by means of a mild work-up with H2O2.(72) Another 
important change to the reaction could be to minimise the usage of toxic azocarboxylates by 
using a catalytic amount and regenerating it in situ with an oxidant (stoichiometric amount) 
such as BAIB.(73)  
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Scheme 15. (a) NaN3, H2O, NH4Cl, DMF, 120 °C, 95 %  (b) Ac2O, pyridine, 0° C  (c) Tf2O,  
pyridine, DCM, - 10 °C, (d) NaN3, DMF, 65 % (2 Steps) 
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The opening of the epoxide ring in compound 32 by nucleophilic substitution was carried out 
with NaN3, NH4Cl and H2O in DMF at 120°C to give an isomeric mixture of products 34 and 
35 (ratio 40:60) in 95% combined yield. The ratio observed for the isomeric products was 
against the prediction of the Fürst-Plattner rule which predicts the transdiaxial isomer 34 to be 
the predominant product.(74,75) The reason for the unexpected ratio could be due to the 
difference in the stability of transient positive charges formed in the carbon atoms present at 
the C-2 and C-3 positions during the nucleophilic substitution process. The positive charge at 
the C-2 position (formed by N3‒ ion attack at the C-2 carbon atom producing the diaxial 
isomer 34) would be less stable relative to the positive charge on the C-3 carbon atom 
(formed by N3‒ ion attack at C-3 carbon atom producing the diequatorial isomer 35) because 
of the proximity of the C-2 carbon to the anomeric centre. Another hindrance to nucleophilic 
attack at the C-2 position could be the orientation of the phenyl group in the anomeric 
position, which would create steric strain on the incoming azide nucleophile. Nevertheless, 
the unexpected major product, the diequatorial isomer 26, happened to be more amenable to 
the subsequent reactions. So, the reaction was optimised to get a maximum ratio of the 
diequatorial isomer 35 considering its advantages over the other isomer 34 in the subsequent 
substitution reaction (see scheme 15). In the process of obtaining more of the gluco isomer 
35, several variations in reagents and reaction conditions were tried. The introduction of 
CsF.(76) and tetraethyl ammonium chloride (TEAC) did not increase the ratio of the desired 
isomer. Reactions with NaN3 or LiN3(77) (20% in water) without using any catalyst were also 
tried but were not successful. The ideal temperature of the reaction (with NaN3, NH4Cl, H2O) 
was found to be 120 ºC after the reactions at low temperatures (80-110 ºC) failed to produce 
full conversion while the reactions at higher temperatures (130-150 ºC) produced an 
undesired ratio. So, the isomeric products (34 and 35, which can be used as a mixture for the 
subsequent reaction) were eluted as a mixture using flash chromatography. However, for the 
analytical characterisation, the mixture was separated and the individual isomers were 
acetylated. See Figures 10, 11 and 12 for the X-ray structures of the acetylated products 38 
and 39 and the triflate 37, respectively. 
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Figure 10. Crystal structure of 38 
 
 
 
Figure 11. Crystal structure of 39 
 
Figure 12. Crystal structure of 37 
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The mixture of isomeric products containing the altro configured sugar 34 and the gluco 
configured sugar 35 were converted into trifluoromethanesulfonyl (triflate) derivatives 36 and 
37 using Tf2O and pyridine in DCM at –10 ºC. For analytical purposes, triflate compounds 36 
and 37 were separately prepared and characterised. For subsequent reactions, the crude triflate 
mixture was directly used in the next step, i.e. azidation with NaN3 in DMF at RT. 
Interestingly, upon nucleophilic substitution, both triflate isomers were converted into 2,3-
dizido mannose configured sugar 40 in 65% yield. Besides the desired substitution product 
40, a minor elimination product 41 was obtained.(78) As theoretically expected, the elimination 
product originated from the triflate isomer 36, which possesses an anti-periplanar hydrogen 
atom. Incidentally, it was observed by TLC that the rate of nucleophilic substitution of the 
diaxial triflate was higher than that of the diequatorial isomer. Variations in reaction 
conditions such as changes in temperature, solvents (DCM and 1,4-dioxane) and the mode of 
addition of NaN3 did not alter the substitution-elimination ratio of the reaction. Both product 
40 and 41 were characterised by means of X-ray diffraction crystallography (see Fig 13 and 
14). 
Figure 13. Crystal structure of 40 
 
 
       Figure 14. Crystal structure of 41 
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Scheme 16.  (a) CH3COOH, H2O, 90 °C, 80% (b) Ac2O, pyridine, 0°C, 93 % (c) Pd/C, H2, 
CH3OH  (d) Ac2O, pyridine, 0°C (e) CH3ONa(0.5 M),CH3OH (45 %, 3 steps) 
 
After successful preparation of 2,3-diazido-2,3-dideoxy mannopyranoside 40, it was used in a 
series of simple protection group modifications. Hydrolysis of the benzylidene acetal group in 
compound 40 was carried out using 80% aqueous acetic acid. Stirring the reaction at 90 °C 
provided the unprotected sugar 42 in 79% yield.(43) (See Fig. 15 for the X-ray structure of the 
acetylated product 43). Next, the transformation of azido groups in compound 42 in to 
acetamido groups was carried out in three steps. First, reduction of the azido groups with a Pd 
(10% on activated charcoal) catalyst over an atmosphere of H2 gave the free diamino 
compound 44. Subsequent acetylation with acetic anhydride in pyridine at 0 °C provided the 
completely acetylated product 45 which was selectively de-acetylated with 0.5 M CH3ONa to 
get 2,3-diacetamido-2,3-dideoxy mannopyranoside 46 in 45% overall yield (in three steps). 
Similar reactions for the glucose isomer described in Chapter 1 provided better yield.  
 
Figure 15. Crystal structure of 43 
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2.3.2 Synthesis of Methyl 2,3-diacetamido-2,3-dideoxy mannouronate 
Procedures described in the literature  
Oxidation of the primary hydroxyl group in 2,3-diacetamido-2,3-dideoxy mannopyranoside in 
to an aldehyde group before conversion into a carboxylic acid was reported by Nilsson et 
al.(66) For some reason, the carboxylic acid group was not converted in to an ester, which 
would have been much more easier to handle in the purification and characterisation process.  
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Figure 16. M.Nilsson et al: Preparation of diacetamido manno uronic acid 
 
Proven method and their optimization 
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Scheme 17.  (a)TEMPO, BAIB, DCM, H2O (b) TEMPO, TCCA, pyridine, -40 °C (c) Br2, 
H2O, CH3OH. 
 
Oxidation of 46 under conditions similar to those used for the corresponding glucose and 
galactose derivatives (TEMPO, BAIB and H2O) did not result in the formation of desired 
carboxylic acid product.(79) The conversion of the starting material to the product was seen by 
TLC, but after work-up, the product could not be isolated. Attempts made to isolate the 
organic product from the aqueous layer were unsuccessful. TEMPO oxidation with different 
secondary oxidants like NaOCl and Ca(OCl)2 also produced negative results. So a different 
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reaction to prepare the ester 48 through the aldehyde product 47 was developed. 
TEMPO/BAIB(80) oxidation in absolute DCM failed to produce the desired aldehyde product. 
TEMPO oxidation with NCS (N-chlorosuccinimide) in the presence of TBACl did not result 
in any conversion of the starting material.(81) The reaction with TEMPO and TCCA 
(trichloroisocyanuric acid) using DCM as the solvent showed very little conversion. So, using 
TEMPO and TCCA as an oxidation system, a variety of solvents and temperature conditions 
were tried. Finally, the reaction showed complete conversion of the starting material when the 
reaction was carried out with pyridine at –35°C.(82) After work-up and isolation (column 
chromatography) of the product, it was characterised as a mixture by NMR spectroscopy.  
But, the observation of an aldehyde proton peak in the spectrum confirmed the formation of 
the aldehyde product. So, after completion of the reaction, without purification, the next step, 
i.e. an oxidative esterification reaction using Br2/H2O and NaHCO3(83) was also tried, but it 
also gave a mixture of products 48 which could not be isolated or characterised 
 
2.3.3 Improvement in the synthesis of 2,3-diacetamido-2,3-dideoxy-D- mannouronate   
Following the failure of the oxidation reactions of phenyl 2,3-diacetamido-2,3-dideoxy-β-D-
mannopyranoside, a modification to the present scheme was followed. Instead of performing 
the oxidation reaction with 2,3-diacetamido compound 46 as the starting material; compound 
42 carrying two azido groups instead of the acetamido groups at the C-2 and C-3 positions 
was used. Due to the successful usage of the TEMPO/BAIB system in the previous chapters, 
it was selected as the reagent of choice for the oxidation reaction.  
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Scheme 18. (a) TEMPO, BAIB, DCM, H2O (b) CH2N2, CH3OH, 79 % (2 steps) (c) BzCl, 
pyridine, DCM, –5 °C, 87 %  
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Remarkably, the TEMPO/BAIB oxidation of diazide 42 to carboxylic acid 49, which was 
directly converted in to ester 50 using CH2N2 in absolute methanol, proceeded with a 
excellent yield of 79%. Unlike the earlier TEMPO/BAIB oxidation of acetamido sugars (8, 11 
and 20), the reaction did not have a critical time limit and furthermore it was highly 
reproducible and scalable (up to 5 g). Benzoylation was done with the addition of BzCl into a 
mixture of compound 50 in pyridine and DCM at 0 °C to get compound 51 in a good yield of 
87%. (See Fig. 17 for the X-ray structure of the compound 51.) 
 
Figure 17. Crystal structure of 51 
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Scheme 19.  Scheme (a) Pd/C, H2,CH3OH 
 
The reduction of 51 using Pd/C and H2 resulted in cyclisation of the diamine product in to δ-
lactam 52. The side reaction proceeded by simple displacement of the methoxy group by the 
amino group at the C-2 position. 
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Scheme 20. (a) Pd/C, H2,CH3OH 
 
To avoid this problem, direct reduction of the carboxylic acid 49 was tried to reduce the 
chance of cyclisation due to the poor leaving group ability of the OH group in the carboxylic 
acid. However, the reaction, which was carried out using Pd on activated charcoal in an H2 
atmosphere, was non-reactive. Another problem with the reaction was the purification of its 
starting material 49. The carboxylic acid compound could not be completely purified even 
after repeated attempts using column chromatography (three times). So, considering the 
practical difficulty in the whole process, further trials of the reaction were not continued.  
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Scheme 21. (a) Thioacetic acid, 2,6-lutidine, 1,4-dioxane, 100 °C, 70 % (b) Raney Ni, H2, 
Ac2O, EtOAc/MeOH, 83 % 
 
To overcome the problem of cyclisation, the azido group at the C-3 position of compound 51 
was directly and selectively converted to an acetamido group by heating the substance with 
thioacetic acid, 2,6-lutidine in 1,4-dioxane at 100 °C for 24 hours.(84) The reaction proceeded  
through a cyclo addition mechanism, where the azido group was directly converted to the 
acetamido group without the formation of the free amino group (Scheme 21). The azido group 
at the C-2 position was non-reactive, probably due to inadequate space for the cyclo addition 
mechanism to take place. The reaction proceeded with a yield of 70%, producing compound 
53 with about 10% of the recovered starting material 51 along with 10% of compound 54 
(product of the next reaction). The partially reduced product 53 could be used as a glycosyl 
donor for glycosylation reactions with a non-participating azido group at the C-2 position. 
Finally, the conversion of the azido group into an acetamido group(85) was carried out using 
Raney nickel,(86) H2 and Ac2O (in situ reduction-acetylation) in a mixture of EtOAc/MeOH to 
give compound 53 in 83% yield. Surprisingly, the reaction without the use of Ac2O did not 
show any conversion (to the amine).  
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Scheme 22. Mechanism of thioacid cyclo addition. 
51
OBzO
N3
N3
OAc
OCH3O
55
a
 
Scheme 23.  (a) Ac2O, HClO4 (70%), 25 % 
Finally, acetolysis of the phenyl group at the anomeric position was performed using a 
catalytic amount of HClO4 (70%) in Ac2O to give the final product 55 in 25% yield. Different 
catalysts, such as 0.3% H2SO4, 10% H2SO4 with silica, 10% PTSA, TMSCl, BF3.Et2O and 
TFA,(87) as reported in literature,(88) were tried to improve the yield, but were not successful. 
2.3.4 Summary 
Overall, the preparation of methyl(acetyl 2,3-diazido-2,3-dideoxy-4-benzoyl-β-D-
mannopyranoside)uronate proceeded with good novelty and outcomes. The preparation of an 
epoxide ring system in sugars, which is a challenging task, was achieved through many initial 
probing reactions. The preparation was performed in high yield and in a large scale in 
comparison to the literature methods. Subsequent epoxide ring opening reactions were also 
performed with good novelty by using both compounds of the isomeric mixture as the raw 
material for subsequent reactions. The most challenging of all, the oxidation reaction, was 
dealt with carefully, with the knowledge acquired from earlier reactions of glucose and 
galactose isomers.  
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3. Summary and outlook 
The synthesis of glucose, galactose and mannose derivatives of 2,3-diacetamido uronates was 
initiated with the preparation of the corresponding 2,3-diacetamido pyranoside derivatives 
which were subjected to the crucial oxidation reaction.  
3.1 Synthesis of 2,3-diacetamido pyranosides 
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Scheme 24. Synthesis of 2,3-diacetamido gluco and galacto pyranosides 
 
With careful consideration of the existing methods available in the literature, the preparation 
of 2,3-diacetamido-2,3-dideoxy-α-D-glucopyranoside was improved by modifications of the 
existing reaction conditions. The 2,3-diacetamido-2,3-dideoxy-α-D-galactopyranoside was 
directly prepared from the glucose isomer by simple inversion of the configuration at the C-4 
position.  
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                            Scheme 24. Synthesis of 2,3-diacetamido mannopyranoside 
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The synthesis of 2,3-diacetamido mannopyranoside was carried out via the preparation and 
opening of the crucial epoxide intermediate. The reactions proceeded with good yield and are 
prepared in good scale.  
 
3.2 Oxidation of 2,3-diacetamido pyranosides to uronates 
As reported in literature, the crucial oxidation reactions were carried out using the selective 
TEMPO/BAIB reagent system. After careful optimisation of the reaction conditions, the 2,3-
diacetamido glucose and galactose pyranosides underwent the oxidation with good yields, but 
the scale up of the reactions were only up to 400 mg. Moreover, the reactions in case of 2,3-
diacetamido mannose pyranosides were not successful.  
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Scheme 24. Literature method 
 
After extensive optimisation of the reaction conditions and choice of substrates, 
improvements were achieved according to the yield and the scale up of the oxidation 
reactions. Unlike the methods reported in literature, where diacetamido pyranosides were 
used as substrates for the oxidation, we performed the reactions using mono azido derivatives 
(for glucose and galactose) and diazido derivative (for mannose). The following reactions of 
benzoylation and reductive cleavage of anomeric groups also proceeded with good yields. 
The scale up of the reactions was also good and the total number of steps required to prepare 
the final compound was also minimized by the modified method. (see Table 1). In general, it 
was found that the azido groups were better groups for the oxidation reactions than the 
corresponding acetamido groups 
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Scheme 25. Modified method 
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So, herewith, we report an efficient synthetic method for the preparation of 2,3-diacetamido 
pyranosides, which can be used to prepare biologically important oligosaccharides.  
 
 
  
 
Literature method Modified method 
Yield 
% 
Steps 
 
Scale up 
(g) 
Yield 
% 
Steps 
 
Scale up 
(g) 
Glucose derivative 5.6 11 0.4 12.2 8 2 
§Galactose derivative 2.6 13 0.4 9.5 10 2 
Mannose derivative - - - 15.3 9 5 
 
Table 1. Comparison of overall yields and total number of steps.
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4. Experimental  Part  
4.1. General methods  
Melting points were determined with a Boetius micro-heating plate BHMK 05 (Rapido, 
Dresden) and were not corrected. Optical rotation was measured for solutions in a 2-cm cell 
with an automatic GYROMAT polarimeter (Dr.Kernchen Co.). 1H NMR spectra (250.13 
MHz, 300.13 MHz, and 500.13 MHz) and 13C NMR spectra (62.9 MHz, 75.5 MHz and 
125.8 MHz) were recorded on Bruker instruments AC 250, ARX 300, and AVANCE 500 
with CDCl3 or DMSO-d6 as solvents. The calibration of spectra was carried out on solvent 
signals (CDCl3: δ1H 7.25, δ13C 77.0; DMSO-d6: δ1H 2.50, δ13C 39.7). 1H and 13C NMR 
signals were assigned by DEPT and two-dimensional 1H, 1H COSY, and 1H, 13C correlation 
spectra (HMBC and HSQC). Mass spectra were recorded on an AMD 402/3 spectrometer 
(AMD Intectra GmbH). Elemental analysis was performed on a CHNS-Flash-EA-1112 
instrument (Thermoquest). For the X-ray structural determination of compounds 37, 38, 39, 
40, 41, 43 and 51 in  X8Apex system with CCD area detector was used (λ = 0.71073 Å, 
graphite monochromator). The structures were deduced by direct methods (Bruker-
SHELXTL). The refinement calculations were carried out using the full-matrix least-squares 
method of Bruker SHELXTL, Vers.5.10, Copyright 1997, Bruker Analytical X-ray Systems. 
All non-hydrogen atoms were refined anisotropically, and the hydrogen atoms were put into 
theoretical positions and refined using the riding model. All washing solutions were cooled to 
5°C. Reactions were monitored using thin-layer chromatography (TLC, Silica Gel 60, F254, 
MerckKGaA). The spots were made visible by immersing the TLC plates into a methanolic 5 
% v/v H2SO4 solution and charring with a heat gun up to 1 min. Preparative flash 
chromatography was performed by elution from columns of slurry-packed Silica Gel 60 
(Merck, 63–200 µm). All solvents and reagents were purified and dried according to standard 
procedures.(89) After workup, solvents were evaporated at reduced pressure with a rotary 
evaporator. For low boiling organic solvents (B.P below 120°C), a water bath with 40 °C 
temperature was used and for higher boiling solvents (such as DMF and DMSO) higher 
temperatures up to 60 °C was used.  
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4.2 Synthesis of methyl 2,3-diacetamido-2,3-dideoxy-D-glucuronate 
4.2.1. Benzyl 2-acetamido-4,6-O-benzylidene-2-deoxy-α-D-glucopyranoside (3)  
O
HO
AcHN
O
O
Ph
OBn  
N-Acetyl-D-glucosamine (1, 5.09 g, 23.0 mmol) was dissolved in a solution of hydrochloric 
acid in benzyl alcohol (1.28 M, 43.7 ml, prepared by adding 3.7 mL of acetyl chloride to 40 
ml dry benzyl alcohol). After stirring for 3–4 h at 55–60 °C (monitored by TLC, CHCl3-
MeOH 3:1)(90,91) the temperature was reduced to 35 °C. Benzaldehyde dimethyl acetal (6.0 
mL, 40 mmol) was then added and after stirring overnight at 35 ºC, the reaction mixture was 
completely solidified. The solid was filtered off and dissolved in a minimum amount of 
pyridine. Addition of ice cold water gave rise to crystallisation. Finally, the crystalline 
precipitate was filtered off and co-distilled several times with a mixture of toluene and ethanol 
(5:1, v/v) until the odour of pyridine disappeared. Recrystallization from ethanol provided 3 
(5.05 g, 55%) as colourless crystals. 
mp 263–264 °C (EtOH); lit.(92) 263–264 °C. 
[α] 22D +151.9 ° (c 1.0, CHCl3: MeOH 1:1 v/v), [α]
22
D +117 (c 1.0, pyridine); Lit.
(93) 
[α] 20D +108,0 (c 1.0, pyridine). 
Rf 0.48 (solvent: CHCl3-MeOH 6:1). 
1H NMR (300.13 MHz, DMSO-d6) δ = 8.01 (d, 1H, 3J2,NH = 8.0 Hz, NH); 7.48-7.29 (m, 10H, 
Ph); 5.62 (s, 1H, H-7); 4.81 (d, 1H, 3J1,2 = 3.7 Hz, H-1); 4.70 (d, 1H, 2J = 12.5 Hz), 4.49 (d, 
2J= 12.5 Hz) (CH2Ph); 4.15 (m, 1H, H-6eq); 3.86 (ddd, 1H, 3J2,3 = 10.2 Hz, 3J2,NH = 8.0 Hz, 
3J1,2 = 3.7 Hz, H-2); 3.79-3.65 (m, 3H, H-3, H-5, H-6ax); 3.52 (’t’, 1H, 3J3,4 = 3J4,5 = 8.8 Hz, 
H-4); 1.85 (s, 3H, CH3CO). 
13C NMR (75.5 MHz, DMSO-d6) δ = 169.3 (COCH3); 137.90, 137.87 (i-Ph(7), i-CH2Ph); 
129.0 (p-Ph(7)); 128.4, 128.2 (m-Ph(7), m-CH2Ph); 127.8 (o-CH2Ph); 127.7 (p-CH2Ph); 126.5 
(o-Ph(7)); 101.0 (C-7); 97.1 (C-1); 82.2 (C-4); 68.7 (CH2Ph); 68.2 (C-6); 67.4 (C-3); 63.0 (C-
5); 54.4 (C-2); 22.7 (COCH3). 
C22H25NO6(399.44):  
Calcd.: C, 66.15; H, 6.31; N, 3.51.  
Found: C, 65.41; H, 5.80; N 3.25. 
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4.2.2. Benzyl 2-acetamido-4,6-O-benzylidene-2-deoxy-3-O-mesyl-α-D-glucopyranoside 
(4)   
    
O
MsO
AcHN
O
O
Ph
OBn  
Over the course of 1 h methanesulfonyl chloride (13.9 mL, 180 mmol) was added dropwise to 
a stirred soln of compound 3 (23.97 g, 60 mmol) in dry pyridine (315 mL) at 0 °C. After 
stirring for 12 h at that temperature (monitored by TLC, CHCl3-MeOH 6:1), the reaction 
mixture was slowly poured into ice-water (300 mL). The precipitate was filtered, washed with 
cold water, and dried. Crystallisation from ethanol provided 4 (23.49 g, 82%) as colourless 
crystals. 
mp 198–199 °C (EtOH); lit.(94) 198–199 °C. 
[α] 22D +60.5(c 1.0, DMSO); Lit.
(95) [α] 25D +76.0 (c 1.0, pyridine).  
Rf 0.71 (CHCl3-MeOH 6:1). 
1H NMR (300.13 MHz, DMSO-d6) δ = 8.21 (d, 1H, 3J2,NH = 9.8 Hz, NH); 7.47-7.30 (m, 10H, 
Ph); 5.72 (s, 1H, H-7); 4.87 (d, 1H, 3J1,2 = 3.7 Hz, H-1); 4.75 (d, 1H, 2J = 12.5 Hz), 4.56 (d, 2J 
= 12.5 Hz) (CH2Ph); 4.74 (dd, 1H, 3J2,3 = 10.5 Hz, 3J3,4 = 9.2 Hz, H-3); 4.31 (ddd, 1H, 3J2,3 = 
10.5 Hz, 3J2,NH = 9.8 Hz, 3J1,2 = 3.7 Hz, H-2); 4.21 (m, 1H, H-6eq); 3.95 (’t’, 1H, 3J3,4 = 3J4,5 = 
9.2 Hz, H-4); 3.87-3.72 (m, 2H, H-5, H-6ax); 3.12 (s, 3H, SO2CH3); 1.88 (s, 3H, CH3CO).  
13C NMR (75.5 MHz, DMSO-d6) δ = 169.8 (COCH3); 137.38, 137.36 (i-Ph(7), i-CH2Ph); 
129.0 (p-Ph(7)); 128.5, 128.29, 128.27 (m-Ph(7), o-CH2Ph, m-CH2Ph); 128.0 (p-CH2Ph); 
126.1 (o-Ph(7)); 100.3 (C-7); 97.6 (C-1); 78.8 (C-4); 78.4 (C-3); 69.3 (CH2Ph); 67.8 (C-6); 
63.1 (C-5); 51.2 (C-2); 38.8 (SO2CH3); 22.5 (COCH3). 
C23H27NO8S (477.53) 
Calcd.: C, 57.85; H, 5.70; N, 2.93; S, 6.71.  
Found: C, 57.49; H, 5.69; N, 2.88; S, 6.80. 
 
4.2.3. Benzyl 2-acetamido-4,6-O-benzylidene-2-deoxy-α-D-allopyranoside (5) 
O
OH
AcHN
O
O
Ph
OBn  
E X P E R I M E N T A L  S E C T I O N  
 32 
A mixture of mesyl compound 4 (20.06 g, 42.0 mmol) and  water free (anhydrous) sodium 
acetate (20.02 g, 244 mmol) in a solution of ethylene glycol monomethyl ether and water (95: 
5, v/v; 250 mL) was stirred under gentle reflux for 48 hours (avoid overheating! TLC: CHCl3-
MeOH 6:1). The mixture was then poured into ice water (ca. 300 mL) and the precipitate was 
filtered off, washed with ice water, co-distilled with toluene (3 x 100 mL) and dried. 
Crystallisation from ethanol provided 5 (13.01 g, 78%) as colourless crystals. 
mp 203–206 °C (EtOH); lit.(95) 203–206 °C; 
[α] 22D +118.0 (c 1.0, DMSO);Lit.
(41) [α] 20D +118.5 (c 1.0, DMSO); 
Rf 0.66 (CHCl3-MeOH 6:1);  
1H NMR (300.13 MHz, DMSO-d6) δ = 7.72 (d, 1H, 3J2,NH = 9.2 Hz, NH); 7.49-7.26 (m, 10H, 
Ph); 5.65 (s, 1H, H-7); 4.92 (d, 1H, 3J3,OH = 4.2 Hz, OH); 4.73 (d, 1H, 3J1,2 = 4.2 Hz, H-1); 
4.69 (d, 1H, 2J = 12.5 Hz), 4.49 (d, 2J = 12.5 Hz) (CH2Ph); 4.20-4.04 (m, 3H, H-2, H-5, H-
6eq); 3.96 (br m, 1H, H-3); 3.74-3.65 (m, 2H, H-4, H-6ax); 1.90 (s, 3H, CH3CO). 
13C NMR (75.5 MHz, DMSO-d6) δ = 169.2 (COCH3); 138.2, 137.9 (i-Ph(7), i-CH2Ph); 129.0 
(p-Ph(7)); 128.3, 128.1 (m-Ph(7), m-CH2Ph); 127.9 (o-CH2Ph); 127.6 (p-CH2Ph); 126.6 (o-
Ph(7)); 100.8 (C-7); 96.7 (C-1); 78.4 (C-4); 69.2 (CH2Ph); 68.5 (C-6); 66.7 (C-3); 57.4 (C-5); 
49.9 (C-2); 22.6 (COCH3).  
C22H25NO6 (399.44): 
Calcd.: C, 66.15; H, 6.31; N, 3.51.  
Found: C, 65.89; H, 6.39; N, 3.09. 
 
4.2.4. Benzyl 2-acetamido-4,6-O-benzylidene-2-deoxy-3-O-mesyl-α-D-allopyranoside (6) 
    
O
MsO
AcHN
O
O
Ph
OBn  
Over the course of 1 h methanesulfonyl chloride (13.7 mL, 138.0 mmol) was added dropwise 
to a stirred soln of compound 5 (9.19 g, 23.0 mmol) in dry pyridine (140 mL) at 0 °C. After 
stirring for 12 h at that temperature (monitored by TLC, EtOAc -MeOH 40:1), the reaction 
mixture was slowly poured into ice-water (150 mL). The aqueous phase was extracted with 
DCM (3 x 100 mL) and the combined organic phases were washed successively with aq 20% 
H2SO4 (3 x 150 mL); cold water (2 x 100 mL), aq NaHCO3 (3 x 150 mL), ice-water (100 
mL), dried, and concentrated. Syrupy crude mesyl derivative 6 was dried under high vacuum 
for 12 h and then used for the next step without further purification.   
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Analytical data was obtained by crystallisation of the crude product in ethanol.  
mp 118–120 °C (EtOH); 
[α] 22D +75.3 (c 1.0 CHCl3);  
Rf 0.3 (Tol- EtOAc 1.5:1); 
1H NMR (500.13 MHz, DMSO-d6) δ = 7.53 (d, 1H, 3J2,NH = 8.7 Hz, NH); 7.47-7.44 (m, 4H, 
Ph); 7.41-7.35 (m, 5H, Ph); 7.30 (m, 1H, Ph);  5.69 (s, 1H, H-7); 5.04 (‘t’, 1H, 3J2,3 = 3J3,4 = 
2.8 Hz, H-3); 4.85 (d, 1H, 3J1,2 = 4.1 Hz, H-1); 4.76 (d, 1H, 3J = 12.5 Hz); 4.62 (d, 1H, 2J = 
12.5 Hz), (CH2Ph); 4.36 (m, 1H, H-2); 4.14 (dd, 1H, 2J6eq,6ax = 10.0 Hz, 3J5,6eq = 5.0 Hz, H-
6eq); 4.04 (dd, 1H, 3J4,5 = 10.0 Hz, 3J3,4 = 2.8 Hz, H-4); 3.99 (d‘t’, 1H, 3J4,5 = 3J5,6ax = 10.0 Hz, 
3J5,6eq = 5.0 Hz, H-5); 3.72 (‘t’, 1H, 2J6eq,6ax = 3J5,6ax = 10.0 Hz, H-6ax); 3.09 (s, 3H, SO2CH3); 
1.92 (s, 3H, CH3CO).  
13C NMR (125.8 MHz, DMSO-d6) δ = 169.8 (COCH3); 137.9, 137.5 (i-Ph(7), i-CH2Ph); 
129.0, 127.5 (p-Ph(7), p-CH2Ph); 128.3, 128.2, 127.5, 126.3 (o-Ph(7), o-CH2Ph, m-Ph(7), m-
CH2Ph); 95.6 (C-1); 76.2 (C-3); 74.8 (C-4); 69.1 CH2Ph); 68.1 (C-6); 58.0 (C-5); 48.5 (C-2); 
38.6 (SO2CH3); 22.5 (COCH3). 
C23H27NO8S (477.53): 
Calcd.: C, 57.85; H, 5.70; N, 2.93; S, 6.71.  
Found: C, 57.52; H, 5.64; N, 2.91; S, 6.75. 
 
4.2.5. Benzyl 2-acetamido-3-azido-4,6-O-benzylidene-2,3-dideoxy-α-D-glucopyranoside 
(7) 
    
O
N3
AcHN
O
O
Ph
OBn  
Carefully dried crude compound 6 (10.03 g; 21.0 mmol) was dissolved in dry DMF (140 mL) 
and sodium azide (13.65 g, 210 mmol) and TBAHS (tetrabutylammonium hydrogen sulphate) 
(7.13 g, 21.0 mmol) was added. The suspension was stirred vigorously at 120 ºC for two 
hours (monitored by TLC: Tol-EtOAc 1:2). The reaction mass was concentrated and the 
residue was dissolved in DCM (400 mL). The organic solution was washed with water (3 x 
150 mL), dried and concentrated. Crystallisation from ethanol provided compound 7 (5.79 g, 
65%, 2 steps) as colourless crystals. 
mp 244–245 °C (EtOH); lit.(41) 244–245 °C; lit.(96) 248–249 °C; 
[α] 22D +97.0(c 0.9, DMSO); lit.
 (41) [α] 20D +97.0 (c 1.0, DMSO);  
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Rf 0.69 (CHCl3-MeOH 6:1); 
1H NMR (500.13 MHz, DMSO-d6) δ = 8.28 (d, 1H, 3J2,NH = 8.2 Hz, NH); 7.45-7.35 (m, 9H, 
Ph); 7.31 (m, 1H, Ph); 5.73 (s, 1H, H-7); 4.83 (d, 1H, 3J1,2 = 3.2 Hz, H-1); 4.74 (d, 1H, 2J = 
12.3 Hz), 4.53 (d, 1H, 2J = 12.3 Hz), (CH2Ph); 4.19 (m, 1H, H-6eq); 3.95-3.86 (m, 2H, H-2, 
H-5); 3.82-3.75 (m, 3H, H-3, H-4, H-6ax); 1.86 (s, 3H, CH3CO).  
13C NMR (125.8 MHz, DMSO-d6) δ = 169.4 (COCH3); 137.6, 137.4 (i-CH2Ph, i-Ph(7)); 
129.1 (p-Ph(7)); 128.4, 128.3, 127.9, 126.1 (o-CH2Ph, m-CH2Ph, o-Ph(7), m-Ph(7)); 127.8 (p-
CH2Ph); 100.6 (C-7); 96.5 (C-1); 79.7 (C-4); 68.0 (C-6); 63.1 (C-3); 60.0 (C-5); 51.8(C-2); 
22.6 (COCH3).  
C22H24N4O5 (424.45): 
Calcd.: C, 62.25; H, 5.70; N, 13.20.  
Found: C, 62.03; H, 5.26; N, 13.08. 
 
4.2.6. Benzyl 2-acetamido-3-azido-2,3-dideoxy-α-D-glucopyranoside (8)  
    
OHO
N3
AcHN
OH
OBn  
Compound 7 (4.24 g, 10 mmol) was dissolved in aq 80% acetic acid (150 mL) and stirred at 
90 ºC. After 45 min (monitored by TLC: CHCl3-MeOH 6:1), the reaction mixture was diluted 
with toluene (100 mL) and concentrated. Following repeated co-distillation with toluene (3 x 
100 mL) the residue was purified by flash chromatography (eluent gradient MeOH 0→ 25% 
in CHCl3) to provide 8 (2.65g, 79%) as colourless crystals. 
mp 195-196 °C; lit. (97) 195–197 °C;  
[α] 22D +130 (c 1.0, CHCl3-MeOH 1 :1 v/v), lit.
(97) [α] 20D +128 (c 1.0, CHCl3-MeOH 1 :1);  
Rf  0.16 (CHCl3-MeOH 6:1); 
1H NMR (300.13 MHz, DMSO-d6) δ = 8.21 (d, 1H, 3J2,NH = 8.0 Hz, NH); 7.43-7.76 (m, 5H, 
Ph); 5.68 (d, 1H, 3J4,OH = 7.0 Hz, OH(4)); 4.72 (d, 1H, 3J1,2 = 2.7 Hz, H-1); 4.69 (d, 1H, 2J = 
12.4 Hz), 4.45 (d, 1H, 2J = 12.4 Hz), (CH2Ph); 4.65 (t, 1H, 3J6,OH = 5.7 Hz OH(6)); 3.75-3.60 
(m, 3H, H-2, H-3, H-6a); 3.57-3.48 (m, 2H, H-5, H-6b); 3.32 (m, 1H, H-4); 1.85 (s, 3H, 
CH3CO).  
13C NMR (75.5 MHz, DMSO-d6) δ = 169.4 (COCH3); 137.8 (i-Ph); 128.4 (m-Ph); 
127.8 (o-Ph); 127.7 (p-Ph); 95.5 (C-1); 73.2 (C-5); 69.4 (C-4); 68.2 (CH2Ph); 64.0 (C-3); 60.5 
(C-6); 51.5 (C-2); 22.6 (COCH3). 
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C15H20N4O5 (336.34):  
Calcd.: C, 53.56; H, 5.99; N, 16.66.  
Found: C, 53.29; H, 5.35; N, 16.42. 
4.2.7. Benzyl 2,3-diacetamido-2,3-dideoxy-α-D-glucopyranoside (11) 
    
OHO
AcNH
AcHN
OH
OBn  
A solution of compound 7 (4.24 g, 10.0 mmol) in aq 80% acetic acid (150 mL) was heated at 
90 ºC for 45 min (monitored by TLC: CHCl3-MeOH 6:1). The reaction mixture was diluted 
with toluene (100 mL) and concentrated. After repeated co-distillation with toluene (3 x 100 
mL) the crude compound 7 was used without further purification for the next step. To a 
solution of crude 8 in methanol (250 mL) 10% palladium-on charcoal (ca. 1.0 g) was added. 
The suspension was stirred for 2 h at room temperature under an atmosphere of hydrogen 
(monitored by TLC: CHCl3-MeOH 5:1). Then, the reaction mixture was filtered over Celite, 
eluted with MeOH and the combined filtrates were concentrated. Freshly distilled acetic 
anhydride (12.0 mL, 115 mmol) was added at 0 °C to a stirred soln of the residue 9 in dry 
pyridine (36 mL). After stirring for 2 h at 0 °C (monitored by TLC: CHCl3-MeOH 10:1), the 
reaction mixture was poured into ice water (200 mL). The aqueous layer was extracted with 
DCM (3 x 50 mL). The combined extracts were washed successively with aq 15% NaHSO4 (3 
x 50 mL), water (70 mL), aq NaHCO3 (3 x 50 mL), water (70 mL), dried and concentrated. 
After drying under high vacuum for 3 h the residue 10 was dissolved in dry methanol (30 mL) 
and sodium methoxide (0.5 M in methanol, 2 mL) was added. After stirring for 2 h at RT 
(monitored by TLC: CHCl3-MeOH 5:1), the reaction mixture was neutralised with IRC-120 
(H+) resin, filtered and concentrated. Flash Chromatography (eluent gradient MeOH 0 → 15% 
in CHCl3) provided compound 11 (1.93 g, 55%) as colourless crystals. 
mp 267–268 °C (EtOH); lit.(40) 267–268 °C (EtOH); 
[α] 22D +146.3 (c 1.0, DMSO); lit.
(40) [α] 20D +146.5 (c 1.0, DMSO);  
Rf 0.4 (CHCl3-MeOH 5:1); 
1H NMR (500.13 MHz, DMSO-d6) δ = 7.71 (d, 1H, 3J3,NH = 9.0 Hz, NH(3); 7.44 (d, 1H, 
3J2,NH = 8.5 Hz, NH(2)); 7.42 (m, 2H, o-Ph); 7.38 (m, 2H, m-Ph); 7.30 (m, 1H, p-Ph); 4.96 ( d, 
1H, 3J4,OH = 6.3 Hz, OH(4)); 4.71 (d, 1H, 3J1,2 = 3.5 Hz, H-1); 4.70 (d, 1H, 2J = 12.3 Hz, 
CH2Ph); 4.56 (t, 1H, 3J6,OH = 6.0 Hz, OH(6)); 4.45 (d, 1H, 2J = 12.3 Hz CH2Ph); 4.00 (d‘t’, 
1H, 3J2,3 = 11.7 Hz, 3J3,4 = 9.5 Hz, 3J3,NH = 9.0 Hz, H-3); 3.81 (ddd, 1H, 3J2,3 = 11.7 Hz, 3J2,NH 
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= 8.5 Hz, 3J1,2 = 3.5 Hz, H -2); 3.65 (m, 1H, H-6a); 3.55-3.48 (m, 2H, H-5, H-6a); 3.29 (d‘t’, 
1H, 3J3,4 = 3J4,5 = 9.5 Hz, 3J4,OH = 6.3 Hz, H-4); 1.80 (s, 3H, CH3CO).  
13C NMR (125.8 MHz, DMSO-d6) δ = 170.5, 169.7 (COCH3); 138.0 (i-Ph); 128.4 (m-Ph); 
128.4 (o-Ph); 127.7 (p-Ph); 95.6 (C-1); 73.7 (C-5); 68.4 (C-4); 68.1 (CH2Ph); 60.9 (C-6); 52.4 
(C-2); 51.7 (C-3); 23.1, 22.6 (COCH3). 
C17H24N2O6 (352.38):  
Calcd.: C, 57.94; H, 6.86; N, 7.95.  
Found: C, 57.61; H, 6.97; N, 7.79. 
 
4.2.8. Methyl(benzyl 2,3-diacetamido-2,3-dideoxy-α-D-glucopyranoside)uronate (13)  
    
OHO
AcHN
AcHN
OBn
OMeO
 
BAIB (bis(acetoxy)iodobenzene) (330 mg, 1.0 mmol)was added to a mixture of 11 (100 mg, 
0.28 mmol) and TEMPO (2,2,6,6-Tetramethylpiperidin-1-yl)oxyl) (8.8 mg, 0.06mmol) in 3 
mL DCM/H2O (ratio 3:1) at RT under stirring. The reaction was stirred for another 6 hours 
(monitored by TLC: CHCl3-MeOH-AA 10:4:1). After the reaction was complete, under ice 
cooling, 1 mL CH3OH and further 2.5 mL 1 M Na2S2O3.5H2O was added slowly. The layers 
were separated and the aqueous phase was acidified to PH 3 with 1M HCl and extracted with 
ethyl acetate. Then, the combined organic layer was dried with MgSO4 and evaporated under 
vacuum. The crude product 12 was taken directly to the next step with CH2N2 in MeOH. 
After completion of the reaction (monitored by TLC: CHCl3-MeOH-AA 10:4:1), the excess 
CH2N2 was quenched with acetic acid and the reaction mass was concentrated and purified by 
column chromatography (Eluent Gradient: MeOH 0 → 20% in CHCl3) to provide 13 
(75.5mg, 68.14 %) as colourless crystals.  
mp 258-260 °C; 
Rf 0.27 (EtOAC-MeOH 5:1);  
[α] D
22 127.7 ° (c 1.0, CHCl3);  
1H NMR (300.13 MHz, DMSO-d6) δ = 7.77 (d, 1H, 3J3,NH = 8.8 Hz, NH(3)); 7.58 (d, 1H, 
3J2,NH = 8.5 Hz, NH(2)); 7.45-7.27 (m, 5H, Ph); 5.41 (d, 1H, 3J4,OH = 7.0 Hz, OH); 4.76 (d, 1H, 
3J1,2 = 3.1 Hz, H-1); 4.69 (d, 1H, 2J = 12.5 Hz), 4.49 (d, 2J = 12.5 Hz), (CH2Ph); 4.09-3.84 (m, 
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3H, H-2, H-3, H-5); 3.69 (s, 3H, OCH3); 3.58 (d’t’, 1H, 3J3,4 = 3J4,5 = 9.8 Hz, 3J4,OH = 7.0 Hz, 
H-4); 1.80, 1.80 (2s, 6H, CH3CO).  
13C NMR (75.5 MHz, DMSO-d6) δ = 170.2 (COO); 169.85, 169.82 (COCH3); 137.5 (i-Ph); 
128.4 (m-Ph); 128.0 (o-Ph); 127.9 (p-Ph); 96.4 (C-1); 72.6 (C-5); 69.7 (C-4); 68.9 (CH2Ph); 
52.2 (OCH3); 51.8 (C-2); 51.1 (C-3); 23.1, 22.6 (COCH3). 
C18H24N2O7(326.12):  
Calcd.:C, 56.83; H, 6.36; N, 7.36;  
Found: C, 56.67; H, 6.27; N, 7.24; 
 
4.2.9. Methyl(benzyl 2,3-diacetamido-4-O-benzoyl-2,3-dideoxy-α-D-
glucopyranoside)uronate (14)  
    
OBzO
AcHN
AcHN
OBn
OMeO
 
Over the course of 1 h benzoyl chloride (0.3 mL, 2.5 mmol) was added dropwise to a stirred 
soln of compound 13 (380 mg, 1.0 mmol), dry pyridine (6 mL) in dry DCM(6 mL)  at -10 °C. 
After stirring for 2 h at -5 °C (monitored by TLC, CHCl3: MeOH 5:1), the reaction mixture 
was slowly poured into ice-water (15 mL). The aqueous phase was extracted with DCM (3 x 
6 mL), and the combined organic phases were washed successively with aq 15% NaHSO4 (3 
x 6 mL); aq NaHCO3 (3 x 6 mL) and ice-water (6 mL). The crude solution was dried, 
concentrated and purified by column chromatography (Eluent Gradient: MeOH 0 → 5 % in 
CHCl3) to give 14 (324.28 mg, 67 %) as colourless crystals. 
mp.: 126-127°C (EtOAc/Heptane); 
Rf: 0.37 (CHCl3-MeOH 6:1);  
[α] 22D +29.2° (c 1.0, CHCl3);  
1H NMR (500.13 MHz, DMSO-d6) δ = 7.95 (d, 1H, 3J2,NH = 8.8 Hz, NH; 7.93 (d, 1H, 3J3,NH = 
9.8 Hz, NH; 7.88 (m, 2H, o-Bz); 7.66 (m, 1H, p-Bz); 7.52 (m, 2H, m-Bz); 7.44 (m, 2H, o-
CH2Ph); 7.37 (m, 2H, m-CH2Ph); 7.31 (m, 1H, p-CH2Ph); 5.03 (‘t’, 1H, 3J3,4 = J4,5 = 10 Hz, 
H-4); 4.93 (d, 1H, 3J1,2 = 3.5 Hz, H-1); 4.76 (d, 1H, 2J= 12.5 Hz), 4.57 (d, 1H, 2J= 12.5 Hz), 
(CH2Ph); 4.49 (d’t’, 1H, 3J2,3 = 12.0 Hz, 3J3,4 = 10.0 Hz, 3J3,NH = 9.8 Hz, H-3); 4.34 (d, 1H, 
3J4,5 = 10.0 Hz, H-5); 4.14 (ddd, 1H, 3J2,3 = 12.0 Hz, 3J2,NH = 8.5 Hz, 3J1,2 = 3.5 Hz, H-2); 3.53 
(s, 3H, OCH3); 1.83, 1.66 (2s, 6H, CH3CO).  
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13C NMR (125.8 MHz, DMSO-d6) δ = 170.0, 169.8 (CH3CO); 168.4 (COOCH3); 165.3 
(PhCOO9; 137.4 (i-CH2Ph); 129.4 (o-Bz); 129.2 (i-Bz); 128.9 (m-Bz); 128.4 (m-CH2Ph); 
128.0 (o-CH2Ph); 127.9 (p-CH2Ph); 71.6 (C-4); 69.4 (CH2Ph); 69.1 (C-5); 52.4 (OCH3); 50.9 
(C-2); 48.2 (C-3); 22.9, 22.5 (COCH3).  
 
C25H28N2O8(484.18): 
Calcd.: C, 61.97; H, 5.83; N, 5.78;  
Found: C, 62.23; H, 5.91; N, 5.75; 
 
4.2.10. Methyl(benzyl 2-acetamido-3-azido-2,3-dideoxy-α-D-glucopyranoside)uronate (16) 
    
OHO
N3
AcHN
OCH3
OBn
O
 
BAIB (bis(acetoxy)iodobenzene) (2.37 g, 7.38 mmol) was added to a mixture of 8 (1 g, 2.97 
mmol) and TEMPO (2,2,6,6-tetramethyl piperidinyloxy) (92.5 mg, 0.59 mmol) in 30 mL 
DCM/H2O (ratio 3:1) at 0 ºC under stirring. The reaction was stirred for 8 hours at RT 
(monitored by TLC: CHCl3:MeOH:AA 20:1:0.5). 10 mL MeOH and further 25 mL 1 M 
Na2S2O3.5H2O was added slowly at 0 ºC. The layers were separated and the aqueous phase 
was acidified to PH 3 with 1M HCl and extracted with ethyl acetate. Then, the combined 
organic layers were dried with Na2SO4 and evaporated under vacuum. The crude product 15 
was taken directly to the next step with CH2N2 in MeOH. After completion of the reaction 
(monitored by TLC: CHCl3:MeOH:AA 20:1:0.5), excess CH2N2 was quenched with acetic 
acid, the reaction mass was evaporated and co-distilled with toluene and purified by column 
chromatography (eluent gradient MeOH 0 → 2.5% in CHCl3) to provide 16 (853.2 mg, 79 %) 
as colourless crystals. 
mp: 156-157°C; 
Rf: 0.3; (CHCl3:MeOH 30:1); 
[α] 22D + 122.8 ° (c 1.0, CHCl3); 
1H NMR (500.13 MHz, DMSO-d6) δ = 8.26 (d, 1H, 3J2,NH = 8.0 Hz, NH); 7.40-7.30 (m, 5H, 
Ph); 6.06 (d, 1H, 3J4,OH = 7.6 Hz, OH); 4.81 (d, 1H, 3J1,2 = 3.2 Hz, H-1); 4.69 (d, 1H, 2J = 12.5 
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Hz), 4.51 (d, 2J = 12.5 Hz), (CH2Ph); 4.07 (d, 1H, 3J4,5 = 9.8 Hz, H-5); 3.74 (ddd, 1H, 3J2,3 = 
11.3 Hz, 3J2,NH = 8.0 Hz, 3J1,2 = 3.2 Hz, H-2); 3.71 (s, 3H, OCH3); 3.69 (dd, 1H, 3J2,3 = 11.3 
Hz, 3J3,4 = 9.1 Hz H-3); 3.53 (d’t’, 1H, 3J4,5 = 9.8 Hz, 3J3,4 = 9.1 Hz, 3J4,OH = 7.6 Hz, H-4); 1.84 
(s, 3H, CH3CO).  
13C NMR (125.8 MHz, DMSO-d6) δ = 169.4 (COCH3); 169.2 (COOCH3); 137.4 (i-Ph); 
128.5 (m-Ph); 127.9 (p-Ph); 127.8 (o-Ph); 96.2 (C-1); 71.8 (C-5); 71.0 (C-4); 69.1 (CH2Ph); 
63.1 ( C-3); 52.3 (OCH3); 51.2 (C-2); 22.6 (COCH3).  
C16H20N4O6(364.35):  
Calcd.: C, 52.74; H, 5.53; N, 15.38;  
Found:C, 52.31 H, 5.17; N, 15.03;  
4.2.11 Methyl(benzyl 2-acetamido-3-azido-4-O-benzoyl-2,3-dideoxy-α-D-
glucopyranoside)uronate (17) 
    
OBzO
N3
AcHN
OCH3
OBn
O
 
In the course of 1 h benzoyl chloride (0.88mL, 7.56 mmol) was added dropwise to a stirred 
soln of compound 16 (1.13 g, 3.09 mmol) in dry pyridine (11.25 mL) in  DCM (22.5 mL) at 0 
°C. After stirring for 4 h at 0 °C (monitored by TLC: CHCl3:MeOH40:1). DCM (20 mL) was 
added to the reaction mass and the organic solution was washed with 15% cold NaHSO4 (3 X 
15 mL), aq NaHCO3 (3 x 15 mL), brine solution (15 mL) and concentrated under vacuum. 
After repeated co-distillation with toluene (3 x 20 mL) to remove adhering pyridine the 
residue was purified by flash chromatography (Eluent Gradient: EtOAc 0 → 120 % in PE) to 
provide 17 (1.14 g, 89 %) as colourless crystals. 
mp: 160-162 °C;  
Rf: 0.2 (PE-EtOAc 1:1);  
[α] 22D + 25.4 ° (c 1.0, CHCl3); 
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1H NMR (250.13 MHz, DMSO-d6) δ = 8.36 (d, 1H, 3J2,NH = 8.2 Hz, NH); 8.02 (m, 2H, o-Bz); 
7.71 (m, 1H, p-Bz); 7.56 (m, 2H, m-Bz); 7.48-7.30 (m, 5H,Ph(1); 5.13 (‘t’, 1H, 3J4,5 = 10.0 
Hz, 3J3,4 = 9.6 Hz, H-4); 4.98 (d, 1H, 3J1,2 = 3.3 Hz, H-1); 4.77 (d, 1H, 2J = 12.4 Hz), 4.58 (d, 
1H, 2J = 12.4 Hz), CH2Ph); 4.46 (d, 1H, 3J4,5 = 10.0 Hz, H-5); 4.16 (dd, 1H, 3J2,3 = 11.4 Hz, 
3J3,4 = 9.6 Hz, H-3); 4.02 (ddd, 1H, 3J2,3 = 11.4 Hz, 3J2,NH = 8.2 Hz, 3J1,2 = 3.3 Hz, H-2); 3.53 
(s, 3H, OCH3); 1.88 (s, 3H, CH3CO).  
13C NMR (62.9 MHz, DMSO-d6) δ = 169.6 (COCH3); 168.0 (COOCH3); 164.9 (PhCOO); 
137.3 (i-Ph(1)); 134.2 (p-Bz); 129.7 (o-Bz); 129.1 (m-Bz); 128.6 (i-Bz); 128.5 (m-Ph(1)); 
127.9 (o-Ph(1)); 127.9 (p-Ph(1)); 96.1 (C-1); 71.0 (C-4); 69.6 (CH2Ph); 68.3 (C-5); 60.4 (C-
3); 52.6 (OCH3); 51.2 (C-2); 22.6 (COCH3).  
C23H24N4O7(468.46):  
Calcd.: C, 58.97; H, 5.16; N, 11.96; 
Found: C, 58.22; H, 4.62; N, 11.45;  
4.2.12 Methyl(2,3-diacetamido-4-O-benzoyl-2,3-dideoxy-D-glucopyranoside)uronate 
18αβ 
    
OBzO
AcNH
AcHN
OCH3
OH
O
 
To a solution of 17 (200 mg, 0.427 mmol) in dry methanol (3 mL), 10% palladium-on 
charcoal (ca. 88 mg) and freshly distilled Ac2O (0.13 mL, 1.359 mmol) was added and the 
suspension was stirred for 4 hours (monitored by TLC: CHCl3-MeOH 30:1). After completion 
of the reaction, to the reaction mixture containing the crude product 14, acetyl chloride 
(44µL) was added and the suspension was stirred for another 4 hours at room temperature 
under an atmosphere of hydrogen (monitored by TLC: CHCl3-MeOH 10:1).The reaction mass 
was filtered through celite, concentrated and purification by column chromatography (MeOH 
0→ 7.5 % in CHCl3) provided 18αβ (151.5 mg, 90 %) as colourless crystals. Analytical data 
for 14 can be found under Sec. 4.2.9 
mp: 98-100 °C; 
Rf: 0.59 (C3:MeOH 6:1);  
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[α] 22D +57.2° (c 1.0, DMSO);  
α: 
1H NMR (300.13 MHz, DMSO-d6) δ = 7.95-7.81 (m, 3H, o-Bz, NH(3); 7.70 (d, 1H, 3J2,NH = 
8.9 Hz, NH(2)); 7.66 (m, 1H, p-Bz); 7.52 (m, 2H, m-Bz); 7.24 (d, 1H, 3J1,OH = 4.0 Hz, OH); 
5.10 (’t’, 1H, 3J1,OH = 4.0 Hz, 3J1,2 = 3.2 Hz, H-1); 5.01 (’t’, 1H, 3J3,4 = 3J4,5 = 10.0 Hz, H-4); 
4.48 (d, 1H, 3J4,5 = 10.0 Hz, H-5); 4.46-4.40 (m, 1H, H-3); 4.05 (ddd, 1H, 3J2,3 = 11.7 Hz, 
3J2,NH = 8.9 Hz, 3J1,2 = 3.2 Hz, H-2); 3.52 (s, 3H, OCH3); 1.83, 1.65 (2s, 6H, CH3CO).  
13C NMR (75.5 MHz, DMSO-d6) δ = 169.9, 169.8 (CH3CO); 168.9 (COOCH3); 165.3 
(PhCOO); 133.7 (p-Bz); 129.4 (o-Bz); 129.4 (i-Bz); 128.9 (m-Bz); 90.8 (C-1); 71.8 (C-4); 
68.4 (C-5); 52.3 (OCH3); 51.5 (C-2); 48.2 (C-3); 22.9, 22.6 COCH3). 
β: 
1H NMR (300.13 MHz, DMSO-d6) δ = 7.07 (d, 1H, 3J1,OH= 6.6 Hz, OH); 4.79 (dd, 1H, 3J1,2 = 
8.3 Hz, 3J1,OH = 6.6 Hz, H-1); 3.51 (s, 3H, OCH3); 1.77, 1.65 (2s, 6H, CH3CO) (not all signals 
are given).  
13C NMR (75.5 MHz, DMSO-d6) δ = 169.6, 169.4 (CH3CO); 168.4 (COOCH3); 96.0 (C-1); 
72.9, 71.4 (C-4, C-5); 54.5, 52.4 (C-2, C-3); 52.3 (OCH3); 23.0, 22.8 (COCH3) (not all signals 
are given). 
C18H22N2O8(394.38)  
Calcd.: C, 54.82; H, 5.62; N, 7.10; 
Found C, 54.39; H, 5.31; N, 6.87; 
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4.3 Synthesis of Methyl 2,3-diacetamido-2,3-dideoxy-D-galacturonate 
4.3.1. Benzyl 2,3-diacetamido-2,3-dideoxy-4,6-O-dimesyl-α-D-glucopyranoside (19) 
    
OMsO
AcNH
AcHN
OMs
OBn
 
In the course of 30 min methanesulfonyl chloride (4.5 mL, 45.0 mmol) was added dropwise to 
a stirred soln of compound 11 (1.76 g, 5.0 mmol) in dry pyridine (30 mL) at 0 °C. After 
stirring for 45 min at 0 °C (monitored by TLC, CHCl3-MeOH 5:1), the reaction mixture was 
slowly poured into ice-water (100 mL). The aqueous phase was extracted with DCM (3 x 40 
mL), and the combined organic phase was washed with aq NaHCO3 (3 x 50 mL), dried and 
concentrated. After repeated co-distillation with toluene (3 x 50 mL) to remove pyridine, the 
residue was purified by flash chromatography (eluent gradient MeOH 0 → 15% in CHCl3) to 
provide 19 (2.01 g, 79%) as colourless crystals 
mp 207–208 °C (EtOH); lit.(55) 206–207 °C;  
[α] 22D +108.8(c 1.0, CHCl3); lit.
(55) [α] 20D +108.5(c 1.0, DMSO); 
Rf  0.52 (CHCl3-MeOH 5:1); 
1H NMR (500.13 MHz, DMSO-d6) δ = 7.92 (d, 1H, 3J3,NH = 9.5 Hz, NH(3)); 7.84 (d, 1H, 
3J2,NH = 9.1 Hz, NH(2)); 7.45-7.29 (m, 5H, Ph); 4.83 (d, 1H, 3J1,2 = 3.3 Hz, H-1); 4.73 (d, 1H, 
2J = 12.0 Hz), 4.52 (d, 1H, 2J = 12.0 Hz), (CH2Ph); 4.50 (br t, 1H, H-4); 4.41 (dd, 1H, 2J= 
11.4 Hz, 3J5,6a = 2.3 Hz, H-6a); 4.31 (dd, 1H, 2J= 11.4 Hz, 3J5,6b = 4.7 Hz, H-6b); 4.31-4.25 (m, 
1H, H-3); 4.09-4.04 (m, 1H, H-2); 4.03 (ddd, 1H, 3J4,5 = 10.0 Hz, 3J5,6b = 4.7 Hz, 3J5,6a = 2.3 
Hz, H-5); 3.19, 3.17 (2s, 6H, SO2CH3); 1.82, 1.79 (2s, 6H, CH3CO).  
13C NMR (125.8 MHz, DMSO-d6) δ = 170.0, 169.9 (COCH3); 137.3 (i-Ph); 128.4, 128.3 (o-
Ph, m-Ph); 128.0 (p-Ph); 95.6 (C-1); 76.1 (C-4); 69.0 (CH2Ph); 68.1 (C-6); 67.9 (C-5); 51.2 
(C-2); 49.0 (C-3); 38.5, 37.1 (SO2CH3); 23.1, 22.4 (COCH3). 
C19H28N2O10S2(508.12): 
Calcd.:C, 44.87; H, 5.55; N, 5.51; S, 12.61;  
Found: C, 44.99; H, 5.27; N, 5.16; S, 12.33; 
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4.3.2. Benzyl 2,3-diacetamido-2,3-dideoxy-α-D-galactopyranoside (20) 
    
O
HO
AcNH
AcHN
OH
OBn  
A mixture of dimesyl compound 19 (2.54 g, 5.0 mmol) and anhydrous sodium acetate (2.46 g, 
30 mmol) in a solution of ethylene glycol monomethyl ether and water (95: 5, v/v; 65 mL) 
was stirred under gentle reflux for 48 hours (avoid overheating! TLC: CHCl3-MeOH 8:1). 
The mixture was co-distilled with toluene and concentrated. Purification by flash 
chromatography (eluent gradient MeOH 0 → 15% in CHCl3) provided 13 (1.15 g, 65%) as 
colourless crystals. 
mp 253 °C (EtOH); lit. (55) 250-252 °C (EtOH);  
[α] 22D +185.1(c 1.0, DMSO); lit.
 (55) [α] 20D +186.5(c 1.0, DMSO); 
Rf 0.21 (CHCl3-MeOH 8:1); 
1H NMR (500.13 MHz, DMSO-d6) δ = 7.63 (d, 1H, 3J2,NH = 8.5 Hz, NH(2)); 7.55 (d, 1H, 
3J3,NH = 8.2 Hz, NH(3)); 7.40 (m, 2H, o-Ph); 7.35 (m, 2H, m-Ph); 7.29 (m, 1H, p-Ph); 4.95 (br 
s, 1H, OH); 4.74 (d, 1H, 3J1,2 = 3.5 Hz, H-1); 4.69 (d, 1H, 2J = 12.3 Hz, CH2Ph); 4.63 (br s, 
1H, OH); 4.44 (d, 1H, 2J = 12.3 Hz, CH2Ph); 4.18 (ddd, 1H, 3J2,3 = 12.3 Hz, 3J2,NH = 8.5 Hz, 
3J1,2 = 3.5 Hz, H-2); 4.09 (ddd, 1H, 3J2,3 = 12.3 Hz, 3J3,NH = 8.2 Hz, 3J3,4 = 2.5 Hz, H-3); 3.77 
(br s, 1H, H-4); 3.72 (dt, 1H, 3J5,6 = 6.3 Hz, 3J4,5 = 1.0 Hz, H-5); 3.54-3.44 (m, 2H, H-6); 1.81, 
1.80 (2s, 6H, CH3CO).  
13C NMR (125.8 MHz, DMSO-d6) δ = 170.0, 169.7 (COCH3); 138.1 (i-Ph); 128.4 (o-Ph); 
127.8 (m-Ph); 127.6 (p-Ph); 96.0 (C-1); 71.7 (C-5); 68.1 (CH2Ph); 66.2 (C-4); 60.7 (C-6); 
49.0 (C-3); 47.3 (C-2); 22.9, 22.7 (COCH3). 
C17H24N2O6 (352.38):  
Calcd.: C, 57.94; H, 6.86; N, 7.95.  
Found: C, 57.58; H, 6.72; N, 7.84. 
4.3.3. Methyl(benzyl 2,3-diacetamido-2,3-dideoxy-α-D-galactopyranoside)uronate (23) 
    
O
HO
AcHN
AcHN
OBn
OMeO
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This compound was prepared from 20 (100 mg, 0.28 mmol) by a procedure similar to that 
used for the preparation of compound 13. Purification by column chromatography (Eluent 
Gradient: MeOH 0 → 20% in CHCl3) provided 23 (75mg, 67.69 %) as colourless crystals. 
mp: 257-258 °C; 
Rf: 0.26 (EtOAc-MeOH 5:1);  
[α] D
22 +159.5 ° (c 1.0, CHCl3); 
1H NMR (300.13 MHz, DMSO-d6) δ = 7.77 (d, 1H, 3JCH,NH = 7.5 Hz, NH); 7.67 (d, 1H, 
3JCH,NH = 7.0 Hz, NH); 7.40-7.25 (m, 5H, Ph); 5.40 (d, 1H, 3J4,OH = 5.7 Hz, OH); 4.87 (d, 1H, 
3J1,2 = 2.8 Hz, H-1); 4.67 (d, 1H, 2J = 12.5 Hz), 4.48 (d, 2J = 12.5 Hz), (CH2Ph); 4.23-4.08 (m, 
3H, H-2, H-3, H-4); 4.40 (d, 1H, 3J4,5 = 1.2 Hz, H-5); 3.65 (s, 3H, OCH3); 1.81, 1.80 (2s, 6H, 
CH3CO).  
13C NMR (75.5 MHz, DMSO-d6) δ = 170.0 (COO); 169.9, 169.0 (COCH3); 137.0 (i-Ph); 
128.4 (m-Ph); 127.8 (o-Ph); 127.7 (p-Ph); 96.5 (C-1); 71.0 (C-5); 69.0 (CH2Ph); 67.1 (C-4); 
51.8 (OCH3); 48.4, 46.5 (C-2, C-3); 22.9, 22.7 (COCH3). 
C18H24N2O7 (326.12):  
Calcd.: C, 56.83; H, 6.36; N, 7.36;  
Found: C, 56.97; H, 6.42; N, 7.53; 
4.3.4. Methyl(benzyl 2,3-diacetamido-4-O-benzoyl-2,3-dideoxy-α-D-galactopyranoside) 
uronate (24) 
    
O
BzO
AcHN
AcHN
OBn
OMeO
 
This compound was prepared from 23 (380 mg, 0.1 mmol) by a procedure similar to that used 
for the preparation of compound 14 (reaction monitored by TLC:CHCl3-MeOH 5:1). 
Purification by flash chromatography (Eluent Gradient: MeOH 0 → 5 % in CHCl3) afforded 
compound 24 (305.23 mg, 62 %) as a colourless syrup.  
mp.: 59 - 61°C (EtOAc/Heptane);  
Rf: 0.60 (CHCl3-MeOH 6:1); 
[α] 22D +77.8° (c 1.0, CHCl3); 
1H NMR (500.13 MHz, DMSO-d6) δ = 8.09 (d, 1H, 3J3,NH = 7.8 Hz, NH(3)); 8.05 (d, 1H, 
3J2,NH = 8.2 Hz, NH(2)); 7.94 (m, 2H, o-Bz); 7.68 (m, 1H, p-Bz); 7.56 (m, 2H, m-Bz); 7.42 
(m, 2H, o-CH2Ph; 7.37 (m, 2H, m-CH2Ph); 7.31 (m, 1H, p-CH2Ph); 5.72 (dd, 1H, 3J3,4 = 2.8 
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Hz, 3J4,5 = 1.6 Hz, H-4); 5.05 (d, 1H, 3J1,2 = 3.4 Hz, H-1); 4.78 (d, 1H, 3J4,5 = 1.6 Hz, H-5); 
4.76 (d, 1H, 2J = 12.3 Hz), 4.55 (d, 1H, 2J = 12.3 Hz), (CH2Ph); 4.47 (ddd, 1H, 3J2,3 = 12.5 
Hz, 3J3,NH = 7.8 Hz, 3J3,4 = 2.8 Hz, H-3); 4.27 (ddd, 1H, 3J2,3 = 12.5 Hz, 3J2,NH = 8.2 Hz, 3J1,,2 = 
3.4 Hz, H-2); 3.52 (s, 3H, OCH3); 1.81, 1.71 (2s, 6H, CH3CO).  
13C NMR (125.8 MHz, DMSO-d6) δ = 170.2, 170.0 (CH3CO); 168.0 (COOCH3); 165.0 
(PhCO); 137.6 (i-CH2Ph); 133.5 (p-Bz); 129.7 (i-Bz); 129.6 (o-Bz); 128.8 (m-Bz); 128.4 (m-
CH2Ph); 127.9 (o-CH2Ph); 127.8 (p-CH2Ph); 96.4 (C-1); 70.0 (C-4); 69.4 (CH2Ph); 69.0 (C-
5); 52.1 (OCH3); 46.9 (C-2); 46.4 (C-3); 22.6, 22.5 (COCH3).  
C25H28N2O8 (484.18):  
Calcd.: C, 61.97; H, 5.83; N, 5.78;  
Found: C, 62.41; H, 5.80; N, 5.74; 
 
4.3.5. Methyl(benzyl 2-acetamido-3-azido-2,3-dideoxy-a-D-galactopyranoside)uronate 
(26) 
    
O
HO
N3
AcHN
OCH3
OBn
O
   
Trifluoromethanesulfonic anhydride (577 µL, 3.43 mmol) was added dropwise at - 10ºC  over 
a period of 30 minutes to a solution of compound 16 (500 mg,1.37 mmol) and pyridine (387.4 
µL 4.79 mmol) in dry DCM (7.5 mL). The reaction was maintained at - 5ºC for another 30 
minutes (monitored by TLC CHCl3:MeOH 40:1). DCM (7.5 mL) was added to the reaction 
mass and the organic solution was washed with 15% cold NaHSO4 (3 X 5 mL) and water (5 
mL). The organic layer was dried with Na2SO4 and evaporated under vacuum. The crude 
product 25 was taken to the next step in DMF (2.5 mL) with NaNO2 (74.6 mg, 10.82 mmol). 
The mixture was stirred overnight at RT (monitored by TLC: Tol (100%)) and diluted with 
DCM (10 mL). The organic solution was washed with water (3 X 3 mL), concentrated and 
purification by flash column chromatography (MeOH 0 → 5 % in CHCl3) provided 26 (538 
mg, 78 %) as colourless crystals. For analytical purpose 25 was purified and characterized.  
mp: 183-185°C 
Rf: 0.3; (CHCl3:MeOH 30:1),  
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[α] D
23  + 169.2° (c 1.0, CHCl3) 
1H NMR (500.13 MHz, DMSO-d6) δ = 8.12 (d, 1H, 3J2,NH = 9.1 Hz, NH); 7.39 (m, 2H, o-Ph); 
7.34 (m, 2H, m-Ph); 7.29 (m, 1H, p-Ph); 5.82 (d, 1H, 3J4,OH = 6.4 Hz, OH); 4.84 (d, 1H, 3J1,2 = 
3.5 Hz, H-1); 4.66 (d, 1H, 2J = 12.6 Hz), 4.49 (d, 1H, 2J = 12.6 Hz), (CH2Ph); 4.43 (d, 1H, 
3J4,5 = 1.3 Hz, H-5); 4.35 (ddd, 1H, 3J2,3 = 12.0 Hz, 3J2,NH = 9.1 Hz, 3J1,2 = 3.5 Hz, H-2); 4.28 
(dd, 1H, 3J4,OH = 6.4 Hz, 3J3,4 = 2.8 Hz, 3J4,5 = 1.3 Hz, H-4); 3.67 (s, 3H, OCH3); 3.66 (dd, 1H, 
3J2,3 = 12.0 Hz, 3J3,4 = 2.8 Hz, H-3); 1.85 (s, 3H, CH3CO).  
13C NMR (125.8 MHz, DMSO-d6) δ = 169.6 (COCH3); 168.7 (COOCH3); 137.7 (i-Ph); 
128.3 (m-Ph); 127.8 (o-Ph); 127.7 (p-Ph); 96.5 (C-1); 71.1 (C-5); 69.0 (CH2Ph); 68.5 (C-4); 
58.6 (C-3); 51.9 (OCH3); 46.3 (C-2); 22.6 (COCH3). 
C16H20N4O6(364.35): 
Calcd.:C, 52.74; H, 5.53; N, 15.38;  
Found:C, 52.91 H, 5.64; N, 15.55;  
51 
Rf: 0.2 (PE:EtOAc 1:1);  
[α D
25 +376.2 ° (c 1.0, CHCl3); 
1H NMR (500.13 MHz, CDCl3) δ = 7.43-7.37 (m, 3H, m-Ph, p-Ph); 7.32 (m, 2H, o-Ph); 5.72 
(d, 1H, 3J2,NH = 9.8 Hz, NH); 4.95 (d, 1H, 3J1,2 = 3.7 Hz, H-1); 4.77 (d, 1H, 2J = 11.7 Hz), 4.56 
(d, 1H, 2J = 11.7 Hz),  (CH2Ph); 4.77 (’t’, 1H, 3J3,4 = 3J4,5 = 9.8 Hz, H-4); 4.46 (d, 1H, 3J4,5 = 
9.8 Hz, H-5); 4.46 (ddd, 1H, 3J2,3 = 10.7 Hz, 3J2,NH = 9.8 Hz, 3J1,2 = 3.7 Hz, H-2); 3.83 (s, 3H, 
OCH3); 3.79 (dd, 1H, 3J2,3 = 10.7 Hz, 3J3,4 = 9.8 Hz, H-3); 1.97 (s, 3H, CH3CO).  
13C NMR (125.8 MHz, CDCl3) δ = 169.9 (COCH3); 166.5 (COOCH3); 135.6 (i-Ph); 128.9 
(m-Ph); 128.9 (p-Ph); 128.5 (o-Ph); 118.3 (q, JC,F = 320 Hz, CF3); 96.2 (C-1); 80.7 (C-4); 71.1 
(CH2Ph); 68.9 (C-5); 62.0 (C-3); 53.1 (OCH3); 51.5 (C-2); 23.0 (COCH3). 
C17H19F3N4O8S (496.41):  
Calcd.: C, 41.13; H, 3.86; N, 11.29; S, 6.46  
Found: C, 40.58; H, 3.37; N, 11.02; S, 6.13 
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4.3.6. Methyl(benzyl 2-acetamido-3-azido-2,3-dideoxy-4-O-benzoyl-α-D-
galactopyranoside)uronate) 27 
    
O
BzO
N3
AcHN
OCH3
OBn
O
 
In the course of 1 h benzoyl chloride (0.88mL, 7.56 mmol) was added dropwise to a stirred 
soln of compound 26 (1.13 g, 3.09 mmol) in dry pyridine (11.25 mL) in  DCM (22.5 mL) at 0 
°C. After stirring for 4 h at 0 °C (monitored by TLC: CHCl3:MeOH 40:1), DCM (20 mL) was 
added to the reaction mass and the organic solution was washed with 15% cold NaHSO4 (3 X 
15 mL), aq NaHCO3 (3 x 15 mL) and brine solution (15 mL). After concentration under 
vacuum and repeated co-distillation with toluene (3 x 20 mL) to remove adhering pyridine the 
residue was purified by flash chromatography (Eluent Gradient: EtOAc 0 → 120 % in PE) to 
provide 27 (1.14 g, 89 %)as colourless crystals. 
mp: 196-198°C;  
Rf: 0.2 (PE:EtOAc 1:1);  
[α] D
23 189.3 ° (c 1.0, CHCl3); 
1H NMR (500.13 MHz, DMSO-d6) δ = 8.29 (d, 1H, 3J2,NH = 8.5 Hz, NH); 7.93 (m, 2H, o-Bz); 
7.70 (m, 1H, p-Bz); 7.57 (m, 2H, m-Bz); 7.43 (m, 2H, o-Ph(1)); 7.38 (m, 2H, m-Ph(1)); 7.32 
(m, 1H, p-Ph(1)); 5.95 (dd, 1H, 3J3,4 = 2.8 Hz, 3J4,5 = 1.3 Hz, H-4); 5.03 (d, 1H, 3J1,2 = 3.2 Hz, 
H-1); 4.80 (d, 1H, 3J4.5 = 1.3 Hz, H-5); 4.74 (d, 1H, 2J = 12.2 Hz), 4.57 (d, 1H, 2J = 12.2 Hz), 
(CH2Ph); 4.32 (dd, 1H, 3J2,3 = 12.0 Hz, 3J3,4 = 2.8 Hz, H-3); 4.26 (ddd, 1H, 3J2,3 = 12.0 Hz, 
3J2,NH = 8.5 Hz, 3J1,2 = 3.2 Hz, H-2); 3.50 (s, 3H, OCH3); 1.85 (s, 3H, CH3CO).  
13C NMR (125.8 MHz, DMSO-d6) δ = 169.7 (COCH3); 167.6 (COOCH3); 164.8 (PhCOO); 
137.4 (i-Ph(1)); 134.0 (p-Bz); 129.4 (o-Bz); 129.1 (m-Bz); 129.0 (i-Bz); 128.4 (m-Ph(1)); 
127.9 (o-Ph(1)); 127.8 (p-Ph(1)); 96.6 (C-1); 70.1 (C-4); 69.5 (CH2Ph); 68.8 (C-5); 57.4 (C-
3); 52.2 (OCH3); 47.6 (C-2); 22.6 (COCH3). 
C23H24N4O7(468.46): 
Calcd.:C, 58.97; H, 5.16; N, 11.96; Found: C, 58.45; H, 4.74; N, 11.75;  
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4.3.7. Methyl(2,3-diacetamido-2,3-dideoxy-4-O-benzoyl-α-D-galactopyranoside)uronate 
28 
 
    
O
BzO
AcNH
AcHN
OCH3
OH
O
 
To a solution of 27 (200 mg, 0.427 mmol) in dry methanol (3 mL), 10% palladium-on 
charcoal (ca. 88 mg) and freshly distilled Ac2O (0.13 mL, 1.359 mmol) was added and the 
suspension was stirred for 4 hours (monitored by TLC: CHCl3-MeOH 30:1). After completion 
of the reaction, to the reaction mixture containing the crude product 24, acetyl chloride 
(44µL) was added and the suspension was stirred for another 4 hours at room temperature 
under an atmosphere of hydrogen (monitored by TLC: CHCl3-MeOH10:1).The reaction mass 
was filtered through celite, concentrated and purification by column chromatography (MeOH 
0→ 7.5 % in CHCl3) provided 28 (146.5 mg, 87 %) as colourless crystals. Analytical data of 
24 can be found under section 4.3.4. 
mp 107-108 °C; 
Rf: 0.55 (CHCl3:MeOH 6:1);  
[α] 22D +102.6° (c 1.0, CHCl3);  
1H NMR (500.13 MHz, DMSO-d6) δ = 7.98 (d, 1H, 3J3,NH = 7.8 Hz, NH(3)); 7.93 (m, 2H, o-
Bz); 7.84 (d, 1H, 3J2,NH = 8.4 Hz, NH(2)); 7.67 (m, 1H, p-Bz); 7.55 (m, 2H, m-Bz); 7.07 (d, 
1H, 3J1,OH = 4.2 Hz, OH); 5.68 (dd, 1H, 3J3,4 = 3.2 Hz, 3J4,5 = 1.5 Hz, H-4); 5.22 (dd, 1H, 3J1,OH 
= 4.2 Hz, 3J1,2 = 3.2 Hz, H-1); 4.86 (d, 1H, 3J4.5 = 1.5 Hz, H-5); 4.41 (ddd, 1H, 3J2,3 = 12.3 Hz, 
3J3,NH = 7.8 Hz, 3J3,4 = 3.2 Hz, H-3); 4.19 (ddd, 1H, 3J2,3 = 12.3 Hz, 3J2,NH = 8.4 Hz, 3J1,2 = 3.2 
Hz,  H-2); 3.51 (s, 3H, OCH3); 1.82, 1.70 (2s, 6H, 2 CH3CO).  
13C NMR (125.8 MHz, DMSO-d6) δ = 170.2, 170.0 (COCH3); 168.5 (COOCH3); 165.0 
(PhCOO); 133.5 (p-Bz); 129.9 (i-Bz); 129.6 (o-Bz); 128.8 (m-Bz); 90.7 (C-1); 70.2 (C-4); 
68.3 (C-5); 52.0 (OCH3); 47.5 (C-2); 46.4 (C-3); 22.7, 22.5 (COCH3). 
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1H NMR (500.13 MHz, DMSO-d6) δ = 8.33 (d, 1H, 3J2,NH = 8.4 Hz, NH); 7.36-7.28 (m, 5H, 
Ph); 6.03 (d, 1H, 3J3,4 = 2.7 Hz,H-4); 5.20 (d, 1H, 3J1,2 = 2.7 Hz, H-1); 4.75 (d, 1H, 2J = 12.3 
Hz), 4.68 (d, 1H, 2J = 12.3 Hz), (CH2Ph); 4.05 (ddd, 1H, 3J2,3 = 10.0 Hz, 3J2,NH = 8.4 Hz, 3J1,2 
= 2.7 Hz,  H-2); 3.73 (s, 3H, OCH3); 3.35 (dd, 1H, 3J2,3 = 10.0 Hz, 3J3,4 = 2.7 Hz, H-3); 1.87 
(s, 3H, CH3CO).  
13C NMR (125.8 MHz, DMSO-d6) δ = 169.9 (COCH3); 161.6 (COOCH3); 141.3 (C-5); 137.2 
(i-Ph); 128.3 (m-Ph); 127.8 (p-Ph); 127.7 (o-Ph); 109.1 (C-4); 97.2 (C-1); 70.2 (CH2Ph); 54.8 
(C-3); 52.5 (OCH3); 49.5 (C-2); 22.5 (COCH3).  
4.4   Synthesis of Methyl (acetyl-2,3-diazido-2,3-dideoxy-β-D-mannuronate) 
4.4.1. Phenyl 2,3-O-dimesyl-4,6-O-benzylidene-β-D-glucopyranoside (31) 
    
O
MsO
OMs
O
O
Ph
OPh
 
In the course of 30 min methanesulfonyl chloride (4.25 mL, 45.0 mmol) was added dropwise 
to a stirred soln of 4,6-O-benzylidene-β-D-glucopyranoside (30) (1.72 g, 5.0 mmol) in dry 
pyridine (30 mL) at 0 °C. After stirring for 45 min at 0 °C (monitored by TLC: Tol-EtOAc 
5:1), the reaction mixture was slowly poured in to cold water (100 mL). The crude product 
was filtered and washed with water and further purification was done by re-crystallisation 
with ethanol to provide 31 (2.10 g, 84 %) as colourless crystals. 
mp 117-118°C (EtOH);  
Rf 0.78 (CHCl3-MeOH 6:1);  
[α] 22D +37.8 ° (c 1.02, CHCl3) 
1H NMR (500.13 MHz, CDCl3) δ = 7.29-7.54 (m, 5H, Ph(1)); 7.06-7.35 (m, 5H, Ph(7)); 
 5.58 (s, 1H, H-7); 5.17 (d, 1H, 3J1,2= 7.37 Hz, H-1); 4.98 (t, 1H, 3J2,3 = 3J3,4 = 9.25 Hz, H-3); 
4.92 (dd, 1H, 3J2,3 = 9.25 Hz, 3J1,2 = 7.37 Hz, H-2); 4.45 (dd, 1H, 2J6ax,6eq = 10.25 Hz, 3J5,6eq = 
4.91 Hz, H-6eq); 3.87 (t, 1H, 3J3,4 = 3J4,5 = 9.25 Hz, H-4); 3.86 (t, 1H, 2J6ax,6eq = 3J5,6ax = 10.25 
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Hz, H-6ax); 3.64 (dd, 1H, 3J5,6ax = 10.25 Hz, 3J4,5 = 9.25 Hz, 3J5,6eq = 4.91 Hz, H-5); 3.22, 3.06 
(2s, 6H, 2 CH3SO2) 
13C NMR (125.8 MHz, CDCl3) δ = 156.44, 136.1, 129.76, 129.5, 128.46, 126.0, 124.02, 
117.44 Ph; 102.02 (C-7); 99.79 (C-1); 78.95 (C-3); 78.05 (C-4); 78.03 (C-2), 68.24 (C-6); 
66.09 (C-5); 39.24, 39.77 (CH3SO2) 
C21H24O10S2 (500.08): 
Calcd.: C, 50.39; H, 4.83; S 12.81;  
Found: C, 50.58; H 4.92; S 12.94.  
 
4.4.2. Phenyl 2,3-anhydro-4,6-O-benzylidene-β-D-allopyranoside(32) 
    
O
O
O
O
Ph
OPh
 
0.5 M Sodium methoxide (75 mL) was added  at 60 °C drop wise over a period of 1 h to a stirred 
solution of 31 (5 g,10.0 mmol) in dryTHF/CH3OH (1:1 mixture) (100 mL). After stirring at 75 °C 
for additional 12 h (monitored by TLC: Tol-EA 12:1), the reaction mixture was neutralised with 
IRC-120 (H+) resin, filtered, dried and concentrated. Purification by flash chromatography 
(eluent gradient: EtOAc 0 → 20 % in PE) provided 32 (1.46 g, 45 %) as colourless crystals. The 
side product 33 was also isolated and characterised by NMR. 
mp154-155°C; 
Rf 0.47 (PE:EtOAc 2.5:1); 
[α] D
22 -45.626° (c 1.0, CHCl3); 
1H NMR (300.13 MHz, CDCl3) δ = 7.54 (m, 2H, o-Ph(7)); 7.44-7.30 (m, 5H, m-Ph(1), m-
Ph(7), p-Ph(7)); 7.11-7.05 (m, 3H, o-Ph(1), p-Ph(1)); 5.68 (d, 1H, 4J1,3 = 0.9 Hz, H-1); 5.60 
(s, 1H, H-7); 4.30 (ddd, 1H, 2J= 10.3 Hz, 3J5,6eq = 4.9 Hz, 5J3,6eq = 0.9 Hz, H-6eq); 4.22 (dd, 
1H, 3J4,5 = 9.1 Hz, 3J3,4 = 1.0 Hz, H-4); 3.95 (ddd, 1H, 3J5,6ax = 10.2 Hz, 3J4,5 = 9.1 Hz, 3J5,6eq = 
4.9 Hz, H-5); 3.75 (‘t’, 1H, 2J= 10.3 Hz, 3J5,6ax = 10.3 Hz, H-6ax); 3.66 (br d, 1H, 3J2,3 = 4.3 
Hz, H-3); 3.60 (d, 1H, 3J2,3 = 4.3 Hz, H-2).  
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13C NMR (75.5 MHz, CDCl3) δ = 156.5 (i-Ph(1)); 137.0 (i-Ph(7)); 129.6 (m-Ph(1)); 129.3 (p-
Ph(7)); 128.4 (m-Ph(7)); 126.3 (o-Ph(7)); 122.9 (p-Ph(1)); 116.3 (o-Ph(1)); 102.7 (C-7); 94.6 
(C-1); 77.2 (C-4); 69.0 (C-6); 61.3 (C-5); 55.1, 51.2 (C-2, C-3). 
C19H18O5(326.34):  
Calcd. C, 69.93; H, 5.56  
Found C, 69.82; H, 5.51. 
4.4.3. Phenyl 2,3-anhydro-4,6-O-benzyliden-β-D-mannopyranoside (33) 
OO
O
O
Ph
OPh
 
Rf 0.44 (PE-EtOAc 2.5:1). 
[α] 23D + 35.2 (c 0.9, CHCl3). 
1H NMR (500.13 MHz, DMSO-d6) δ = 7.46 (m, 2H, o-Ph(7)); 7.41-7.38 (m, 3H, m-Ph(7), p-
Ph(7)); 7.33 (m, 2H, m-Ph(1)); 7.11 (m, 2H, o-Ph(1)); 7.04 (m, 1H, p-Ph(1)); 5.94 (d, 1H, 3J1,2 = 
1.0 Hz, H-1); 5.71 (s, 1H, H-7); 4.41 (dd, 1H, 2J = 10.0 Hz, 3J5,6eq = 4.7 Hz, H-6eq); 3.77 (d, 1H, 
3J4,5 = 9.8 Hz, H-4); 3.75 (‘t’, 1H, 2J = 3J5,6ax = 10.0 Hz, H-6ax); 3.59 (d, 1H, 3J2,3 = 3.8 Hz, H-3); 
3.57 (ddd, 1H, 3J5,6ax = 10.0 Hz, 3J4,5 = 9.8 Hz, 3J5,6eq = 4.7 Hz, H-5); 3.53 (dd, 1H, 3J2,3 = 3.8 Hz, 
3J1,2 = 1.0 Hz, H-2).  
13C NMR (125.8 MHz, DMSO-d6) δ = 156.6 (i-Ph(1)); 137.5 (i-Ph(7)); 129.7 (m-Ph(1)); 129.2 
(p-Ph(7)); 128.3 (m-Ph(7)); 126.4 (o-Ph(7)); 122.5 (p-Ph(1)); 116.2 (o-Ph(1)); 101.5 (C-7); 95.9 
(C-1); 73.7 (C-4); 68.4 (C-6); 68.1 (C-5); 54.9 (C-3); 50.3 (C-2). C19H18O5(326.12):   
Calcd. C, 69.93; H, 5.56;  
Found C, 69.46; H, 5.32; 
4.4.4. Phenyl 2,3-anhydro-4,6-O-benzylidene-β-D-allopyranoside (32) 
    
O
O
O
O
Ph
OPh
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Di-iso-propylazo-1,2-dicarboxylate (DIAD, 21.84 g, 108.0 mmol) was added  at 85 °C 
portion wise over 1 h to a stirred solution of phenyl4,6-O-benzylidene-β-D-
glucopyranoside(98-100) (30,12.40 g, 36.0 mmol) and triphenylphosphine (33.05 g, 126.0 
mmol) in dry DMF (180 mL). After stirring for another 12 hat 85 °C (monitored by TLC: Tol-
Acetone 5:1), 20 mL MeOH was added and the reaction mixture was concentrated under 
high-vacuum and the residue was purified by crystallisation from Ethanol to provide 32 (9.05 
g, 77 %) as colourless crystals. 
Analytical data available in section 4.4.2. 
 
4.4.5. Phenyl 2-azido-4,6-O-benzylidene-2-deoxy-β-D-altropyranoside (34) and phenyl 3-
azido-4,6-O-benzylidene-3-deoxy-β-D-glucopyranoside (35) 
O
HO
N3O
O
Ph
OPh
  
O
N3
OH
O
O
Ph
OPh
 
   34      35  
NaN3 (10.27g, 158 mmol), NH4Cl (2.43g, 45.42 mmol) and water (12.69 mL, 705 mmol) was 
added to a solution of compound 32 (9 g, 27.61 mmol) in 135 mL DMF. The mixture was stirred 
at 120ºC for 90 minutes (monitored by TLC: Tol-EtOAc30 :1) and diluted with DCM (300 mL). 
The organic solution was washed with water (3 X 100 mL), concentrated and purification of the 
crude product by flash chromatography (eluent gradient EtOAc 0 → 20% in PE) provided the 
isomer mixture (34 and 35 together, 9.67 g, 95 % yield, isomer ratio 60:40) as colourless crystals.  
34: 
mp 149-151°C,  
Rf: 0.255 (Tol-EtOAc12:1) 
[α] D
23 -98.2 ° (c 1.0, CHCl3)  
1H NMR (500.13 MHz, CDCl3) δ = 7.50 (m, 2H, o-Ph(7)); 7.41 (m, 3H, m-Ph(7), p-Ph(7)); 
7.33 (m, 2H, m-Ph(1)); 7.10-7.05 (m, 3H, o-Ph(1), p-Ph(1)); 5.69 (d, 1H, 3J1,2 = 1.6 Hz, H-1); 
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5.63 (s, 1H, H-7); 4.39 (dd, 1H, 2J6ax,6eq = 10.4 Hz, 3J5,6eq = 5.0 Hz, H-6eq); 4.15 (br ’t’, 1H, H-
3); 4.09 (ddd, 1H, 3J5,6ax = 10.4 Hz, 3J4,5 = 9.8 Hz, 3J5,6eq = 5.0 Hz, H-5); 3.94 (dd, 1H, 3J1,2 = 
1.6 Hz, 3J2,3 = 3.5 Hz, H-2); 3.89 (dd, 1H, 3J4,5 = 9.8 Hz, 3J3,4 = 2.7 Hz, H-4); 3.86 (’t’, 1H, 
2J6ax,6eq = 3J5,6ax = 10.4 Hz, H-6ax); 2.64 (s, 1H, OH).  
13C NMR (125.8 MHz, CDCl3) δ = 156.2 (i-Ph(1)); 136.8 (i-Ph(7)); 129.5 (m-Ph(1)); 129.4 
(p-Ph(7)); 128.4 (m-Ph(7)); 126.2 (o-Ph(7)); 123.0 (p-Ph(1)); 116.3 (o-Ph(1)); 102.1 (C-7); 
96.7 (C-1); 75.9 (C-4); 68.6 (C-3); 68.6 (C-6); 63.8 (C-5); 62.7 (C-2). 
C19H19N3O5(369.13): 
Calcd.:C, 61.78; H, 5.18 N, 11.38  
Found C, 61.55; H, 5.02 N, 11.21 
35: 
mp: 205-207°C;  
Rf: 0.23 (Tol-EtOAc 12:1); 
[α] 24D -33.3 ° (c 1.0, CHCl3);  
1H NMR (500.13 MHz, CDCl3) δ = 7.51 (m, 2H, o-Ph(7)); 7.42-7.37 (m, 3H, m-Ph(7), p-
Ph(7)); 7.33 (m, 2H, m-Ph(1)); 7.10 (m, 1H, p-Ph(1)); 7.05 (m, 2H, o-Ph(1)); 5.60 (s, 1H, H-
7); 5.04 (d, 1H, 3J1,2 = 7.5 Hz, H-1); 4.40 (dd, 1H, 2J6ax,6eq = 10.5 Hz, 3J5,6eq = 4.4 Hz, H-6eq); 
3.85-3.76 (m, 2H, H-3, H-6ax); 3.74 (’t’, 1H, 3J2,3 = 8.0 Hz, 3J1,2 = 7.5 Hz, H-2); 3.66-3.60 (m, 
2H, H-4, H-5); 2.70 (s, 1H, OH). 13C NMR (125.8 MHz, CDCl3) δ = 156.6 (i-Ph(1)); 136.6 
(i-Ph(7)); 129.7 (m-Ph(1)); 129.2 (p-Ph(7)); 128.3 (m-Ph(7)); 126.0 (o-Ph(7)); 123.5 (p-
Ph(1)); 116.9 (o-Ph(1)); 101.6 (C-7); 101.4 (C-1); 79.2 (C-4); 73.3 (C- 2); 68.6 (C-6); 67.5 
(C-5); 64.4 (C-3). 
 
C19H19N3O5 (369.13) : 
Calcd.:C, 61.78; H, 5.18; N, 11.38;  
Found C, 61.91; H, 4.98; N, 11.52; 
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4.4.6. Phenyl 2-azido-4,6-O-benzylidene-2-deoxy-3-O-trifluoromethanesulfonyl-β-D-
altropyranoside (36) 
    
O
TfO
N3O
O
Ph
OPh
 
Trifluoromethanesulfonic anhydride  (382.29 mg, 0.23 mL, 1.35 mmol ) was added, at - 10ºC 
drop wise over a period of 30 minutes to compound 34 (200 mg, 0.542 mmol) and pyridine 
(0.15 mL, 1.90 mmol) in dry CH2Cl2 (4 mL). The reaction was maintained at -5ºC for another 
30 minutes (monitored by TLC Tol-EtOAc 60:1). CH2Cl2 (4mL) was added to the reaction 
mass and the organic solution was washed with 15% cold NaHSO4 (3 X 3 mL) and water 
(3mL). The organic layer was dried with Na2SO4, evaporated under vacuum and purification 
by column chromatography (EtOAc 0 – 15 % in PE) provided 36 (206.88 mg, 77%) as 
colourless syrup. 
Rf 0.61(Tol-EtOAc 20:1); 
[α] D
22 -73.5° (c 1.0, CHCl3);  
1H NMR (500.13 MHz, CDCl3) δ = 7.49-7.44 (m, 2H, o-Ph(7)); 7.41-7.32 (m, 5H, m-Ph(1), 
m-Ph(7), p-Ph(7)); 7.15-7.04 (m, 3H, o-Ph(1), p-Ph(1)); 5.67 (d, 1H, 3J1,2 = 1.6 Hz, H-1); 5.62 
(s, 1H, H-7); 5.23 (dd, 1H, 3J2,3 = 3.5, 3J3,4 = 1.5 Hz, H-3); 4.41 (dd, 1H, 2J6ax,6eq = 10.6 Hz, 
3J5,6eq = 4.0 Hz, H-6eq); 4.26 (dd, 1H, 3J2,3 = 3.5 Hz, 3J1,2 = 1.6 Hz, H-2); 4.12-4.03 (m, 2H, H-
4, H-5); 3.93-3.82 (m, 1H, H-6ax).  
13C NMR (125.8 MHz, CDCl3) δ = 156.8 (i-Ph(1)); 136.3 (i-Ph(7)); 129.8 (m-Ph(1)); 129.4 
(p-Ph(7)); 128.3 (m-Ph(7)); 126.1 (o-Ph(7)); 123.6 (p-Ph(1)); 118.4 (q, JC,F = 320 Hz, CF3); 
116.3 (o-Ph(1)); 102.6 (C-7); 97.3 (C-1); 81.7 (C-3); 72.5 (C-4); 68.6 (C-6); 64.1 (C-5); 61.3 
(C-2). 
C20H18F3N3O7S(501.08):  
Calcd.:C, 47.91; H, 3.62; N, 8.38; S, 6.39  
Found: C, 47.69; H, 3.54;  N, 8.29 S, 6.24 
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4.4.7. Phenyl 3-azido-4,6-O-benzylidene-3-deoxy-2-O-trifluoromethanesulfonyl-β-D-
glucopyranoside (37) 
    
O
N3
OTf
O
O
Ph
OPh
 
This compound was prepared from 35 (200 mg, 0.542 mmol) by a procedure similar to that 
used for the preparation of compound 36 (monitored by TLC: Tol-EtOAc 60:1).Purification 
by flash chromatography (EtOAc 0 – 15 % in PE) afforded compound 37 (220.32 mg, 82 %) 
as colourless crystals. 
mp Decompose on melting  
Rf 0.57(Tol-EtOAc 20:1),  
[α] D
22 -59.8 ° (c 1.0, CHCl3) 
1H NMR (500.13 MHz, CDCl3) δ = 7.50 (m, 2H, o-Ph(7)); 7.44-7.38 (m, 3H, m-Ph(7), p-
Ph(7)); 7.38-7.30 (m, 2H, m-Ph(1)); 7.13 (m, 1H, p-Ph(1)); 7.06 (m, 2H, o-Ph(1)); 5.63 (s, 
1H, H-7); 5.17 (d, 1H, 3J1,2 = 7.8 Hz, H-1); 4.70 (d, 1H, 3J1,2 = 7.8 Hz, H-2); 4.42 (dd, 1H, 
2J6ax,6eq = 10.6 Hz, 3J5,6eq = 4.9 Hz, H-6eq); 3.96 (’t’, 1H, 3J2,3 = 3J3,4 = 9.8 Hz, H-3); 3.84 (dd, 
1H, 2J6ax,6eq = 10.6 Hz, 3J5,6ax = 9.8 Hz, H-6ax); 3.74 (’t’, 1H, 3J3,4 = 9.8 Hz, 3J4,5 = 9.3 Hz, H-
4); 3.62 (ddd, 1H, 3J5,6ax = 9.8 Hz, 3J4,5 = 9.3 Hz, 3J5,6eq = 4.7 Hz, H-5).  
13C NMR (125.8 MHz, CDCl3) δ = 156.1 (i-Ph(1)); 136.1 (i-Ph(7)); 129.8 (m-Ph(1)); 129.4 
(p-Ph(7)); 128.4 (m-Ph(7)); 125.9 (o-Ph(7)); 124.1 (p-Ph(1)); 118.4 (q, JC,F = 319 Hz, CF3); 
117.2 (o-Ph(1)); 101.6 (C-7); 98.8 (C-1); 82.2 (C-2); 79.4 (C-4); 68.3 (C-6); 67.4 (C-5); 62.7 
(C-3). 
C20H18F3N3O7S(501.08): 
Calcd.: C, 47.91; H, 3.62;  N, 8.38; S, 6.39  
Found: C, 47.61; H, 3.49;  N, 8.22; S, 6.18 
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4.4.8. Phenyl 3-O-acetyl-2-azido-4,6-O-benzylidene-2-deoxy-β-D-altropyranoside (38) 
    
O
OAc
N3O
O
Ph
OPh
 
Freshly distilled acetic anhydride (1.0 mL) was added at 0 °C to a stirred soln of compound 
34 (400 mg, 1.08 mmol)in dry pyridine (4.0 mL). After stirring for1 h at RT (monitored by 
TLC: Tol-EtOAc 40:1), the reaction mixture was diluted with toluene and concentrated. 
Traces of acetic acid and pyridine were removed by repeated co-distillation with toluene. 
Purification by flash chromatography (eluent gradient EtOAc 0 → 10% in PE) afforded 
compound 38 (369 mg, 83%) as colourless crystals. 
mp 129-131°C;  
Rf: 0.25 (Tol-EtOAc 40:1); 
[α] D
22  -80.3° (c 1.02, CHCl3); 
1H NMR (500.13 MHz, CDCl3) δ = 7.45 (m, 2H, o-Ph(7)); 7.39-7.35 (m, 3H, m-Ph(7), p-
Ph(7)); 7.34 (m, 2H, m-Ph(1)); 7.11-7.07 (m, 3H, o-Ph(1), p-Ph(1)); 5.59 (s, 1H, H-7); 5.58 
(d, 1H, 3J1,2 = 1.6 Hz, H-1); 5.43 (’t’, 1H, 3J2,3 = 3.5, 3J3,4 = 3.0 Hz, H-3); 5.13-4.06 (m, 2H, 
H-2, H-5); 4.40 (dd, 1H, 2J6ax,6eq = 10.4 Hz, 3J5,6eq = 5.0 Hz, H-6eq); 4.02 (dd, 1H, 3J4,5 = 9.8 
Hz, 3J3,4 = 3.0 Hz, H-4); 3.87 (’t’, 1H, 2J6ax,6eq = 10.4 Hz, 3J5,6ax = 10.0 Hz, H-6ax); 2.15 (s, 
3H, CH3CO).  
13C NMR (125.8 MHz, CDCl3) δ = 169.4 (COCH3); 156.3 (i-Ph(1)); 136.9 (i-Ph(7)); 129.6 
(m-Ph(1)); 129.1 (p-Ph(7)); 128.3 (m-Ph(7)); 126.1 (o-Ph(7)); 123.2 (p-Ph(1)); 116.3 (o-
Ph(1)); 102.0 (C-7); 97.1 (C-1); 73.7 (C-4); 69.1 (C-3); 68.9 (C-6); 64.7 (C-5); 61.1 (C-2); 
20.9 (COCH3). 
C21H21N3O6(411.14):  
Calcd.: C, 61.31; H, 5.14 N, 10.21  
Found: C, 61.17; H, 5.07 N, 10.09 
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4.4.9. Phenyl 2-O-acetyl-3-azido-4,6-O-benzylidene-3-deoxy-β-D-glucopyranoside (39) 
    
O
N3
OAc
O
O
Ph
OPh
 
This compound was prepared from 35 (200 mg, 0.542 mmol)) by a procedure similar to that 
used for the preparation of compound 38 (monitored by TLC: Tol-EtOAc 40:1). Purification 
by flash chromatography (eluent gradient EtOAc 0 → 10% in PE) afforded compound 39 
(396 mg, 89%) as colourless crystals. 
mp 160-162°C;  
Rf 0.24 (Tol-EtOAc 40:1); 
[α] D
22 -61.7° (c 1.0, CHCl3); 
1H NMR (500.13 MHz, CDCl3) δ = 7.51 (m, 2H, o-Ph(7)); 7.41-7.35 (m, 3H, m-Ph(7), p-
Ph(7)); 7.31 (m, 2H, m-Ph(1)); 7.09 (m, 1H, p-Ph(1)); 6.99 (m, 2H, o-Ph(1)); 5.62 (s, 1H, H-
7); 5.18 (dd, 1H, 3J2,3 = 9.8 Hz, 3J1,2 = 7.9 Hz, H-2); 5.11 (d, 1H, 3J1,2 = 7.9 Hz, H-1); 4.42 
(dd, 1H, 2J6ax,6eq = 10.7 Hz, 3J5,6eq = 5.0 Hz, H-6eq); 3.86 (’t’, 1H, 3J2,3 = 3J3,4 = 9.8 Hz, H-3); 
3.85 (’t’, 1H, 2J6ax,6eq = 10.7 Hz, 3J5,6ax = 10.0 Hz, H-6ax); 3.74 (’t’, 1H, 3J3,4 = 9.8 Hz, 3J4,5 = 
9.3 Hz, H-4); 3.65 (ddd, 1H, 3J5,6ax = 10.0 Hz, 3J4,5 = 9.3 Hz, 3J5,6eq = 5.0 Hz, H-5); 2.15 (s, 3H, 
CH3CO). 
13C NMR (125.8 MHz, CDCl3) δ = 169.1 (COCH3); 156.8 (i-Ph(1)); 136.5 (i-Ph(7)); 129.7 
(m-Ph(1)); 129.2 (p-Ph(7)); 128.4 (m-Ph(7)); 126.0 (o-Ph(7)); 123.4 (p-Ph(1)); 116.9 (o-
Ph(1)); 101.6 (C-7); 99.9 (C-1); 79.1 (C-4); 71.5 (C-2); 68.5 (C-6); 67.4 (C-5); 63.1 (C-3); 
20.7 (COCH3). 
C21H21N3O6(411.14):   
Calcd.: C, 61.31; H, 5.14 N, 10.21  
Found: C, 61.11; H, 5.01 N, 10.02 
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4.4.10. Phenyl 2,3-diazido-4,6-O-benzylidene-2,3-dideoxy-β-D-mannopyranoside (40) 
    
O
N3O
O
Ph
OPhN3  
Trifluoromethanesulfonic anhydride (9.89 mL, 58.8 mmol) was added dropwise at – 10 ºC 
over a period of 1.5 h to a mixture of compounds 34 and 35 (8.68 g, 23.52 mmol) and 
pyridine (6.65 mL, 82.32 mmol) in dry DCM (180 mL). The reaction was maintained at - 5ºC 
for another 1 hour (monitored by TLC Tol-EtOAc 30:1). DCM(125 mL) was added to the 
reaction mass and the organic solution was washed with 15% cold NaHSO4 (3 X 80 mL) and 
water (80 mL). The organic layer was dried with Na2SO4 and evaporated under vacuum. The 
crude product was taken to the next step in DMF (135 mL) with NaN3 (4.58 g, 70.56 mmol). 
The mixture was stirred overnight at RT (monitored by TLC: Tol) and diluted with DCM 
(300 mL). The organic solution was washed with water (3 X 100 mL), concentrated and 
purification by flash column chromatography (EtOAc 0 → 15 % in PE) provided 40 (6.051 g, 
65.29 %) as colourless crystals. The side product 41 (1.65 g, 20 %) a colourless crystal 
compound was also isolated and characterized. 
 
40 
mp 152-154°C;  
Rf 0.44 (Tol); 
[α] 23D -70.7° (c 1.02, CHCl3);  
1H NMR (500.13 MHz, CDCl3) δ = 7.50 (m, 2H, o-Ph(7)); 7.41-7.36 (m, 3H, m-Ph(7), p-
Ph(7)); 7.35-7.31 (m, 2H, m-Ph(1)); 7.10 (m, 1H, p-Ph(1)); 7.04 (m, 1H, o-Ph(1)); 5.65 (s, 
1H, H-7); 5.27 (d, 1H, 3J1,2 = 1.4 Hz, H-1); 4.39 (dd, 1H, 2J6ax,6eq = 10.7 Hz, 3J5,6eq = 5.0 Hz, 
H-6eq); 4.12 (dd, 1H, 3J2,3 = 3.6 Hz, 3J1,2 = 1.4 Hz, H-2); 4.07 (dd, 1H, 3J3,4 = 10.2 Hz, 3J4,5 = 
9.2 Hz, H-4); 3.92 (dd, 1H, 2J6ax,6eq = 10.7 Hz, 3J5,6ax = 10.0 Hz, H-6ax); 3.81 (dd, 1H, 3J3,4 = 
10.2 Hz,3J2,3 = 3.6, H-3); 3.55 (ddd, 1H, 3J5,6ax = 10.0 Hz, 3J4,5 = 9.2 Hz, 3J5,6eq = 5.0 Hz, H-5).   
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13C NMR (125.8 MHz, CDCl3) δ = 156.0 (i-Ph(1)); 136.6 (i-Ph(7)); 129.7 (m-Ph(1)); 129.2 
(p-Ph(7)); 128.3 (m-Ph(7)); 125.9 (o-Ph(7)); 123.5 (p-Ph(1)); 116.5 (o-Ph(1)); 101.7 (C-7); 
98.4 (C-1); 76.6 (C-4); 68.4 (C-6); 68.2 (C-3); 63.2 (C-5); 60.4 (C-2). 
C19H18N6O4(394.14):  
Calcd.: C, 57.86; H, 4.60; N, 21.31;  
Found: C, 57.66; H, 4.49; N, 4.51;  
41 
O
N3O
O
Ph
OPh
 
mp 98-100°C; 
Rf 0.47 (Tol); 
[α] 23D + 177.1 ° (c 1.03, CHCl3);  
1H NMR (300.13 MHz, CDCl3) δ = 7.55-7.51 (m, 2H, o-Ph(7)); 7.45-7.40 (m, 3H, m-Ph(7), 
p-Ph(7)); 7.34 (m, 2H, m-Ph(1)); 7.12-7.06 (m, 3H, p-Ph(1), o-Ph(1)); 5.64 (s, 1H, H-7); 5.49 
(dd, 1H, 3J2,3 = 5.3 Hz, 4J3,5 = 1.8 Hz H-3); 4.54 (dd‘t’, 1H, 3J5,6ax = 10.0 Hz, 3J5,6eq = 6.4 Hz, 
5J2,5 = 4J3,5 = 1.8 Hz, H-5); 4.48 (dd, 1H, 2J= 10.0 Hz, 3J5,6eq = 6.4 Hz, H-6eq); 3.84 (‘t’, 1H, 
2J= 3J5,6ax = 10.0 Hz, H-6ax).  
13C NMR (75.5 MHz, CDCl3) δ = 156.4, 156.0 (i-Ph(1), C-4); 136.0 (i-Ph(7)); 129.7 (p-
Ph(7));  129.6 (m-Ph(1)); 128.5 (m-Ph(7)); 126.2 (o-Ph(7)); 123.1 (p-Ph(1)); 116.7 (o-Ph(1)); 
103.8 (C-7); 100.9 (C-3); 97.8 (C-1); 69.7 (C-6); 66.4 (C-5); 56.1 (C-2). 
C20H20N3O4(351.12):  
Calcd.: C, 65.56; H, 5.50; N, 11.47;  
Found: C, 65.43; H, 5.39; N, 11.41;  
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4.4.11. Phenyl 2,3-diazido-2,3-dideoxy-β-D-mannopyranoside (42) 
    
OHO
N3
N3HO
OPh
 
Compound 40 (5.9 g, 0.0149 mol) was dissolved in aq 80% acetic acid (300 mL) and stirred 
at 90 ºC. After 45 min (TLC: Tol-EtOAc 5:1), the reaction mixture was diluted with toluene 
(200 mL) and evaporated. After repeated co-distillation with toluene (3 x 150 mL) the residue 
was purified by flash chromatography (eluent gradient EtOAc 0 → 70% in PE) to provide 42 
(3.73g, 80%) as colourless crystals. 
mp 122-124°C; 
Rf 0.22 (PE-EtOAc1:1); 
[α] D
24 -73.1 ° (c 1.02, CHCl3); 
 
1H NMR (250.13 MHz, CDCl3) δ = 7.33 (m, 2H, m-Ph; 7.07-6.99 (m, 3H, o-Ph, p-Ph); 5.74 
(d, 1H, 3J4,OH = 6.5 Hz, OH(4)); 5.51 (d, 1H, 3J1,2 = 1.2 Hz, H-1); 4.73 (t, 1H, 3J6,OH = 5.8 Hz, 
OH(6)); 4.33 (dd, 1H, 3J2,3 = 3.6 Hz, 3J1,2 = 1.2 Hz, H-2); 3.80 (dd, 1H, 3J3,4 = 9.8 Hz, 3J2,3 = 
3.6 Hz, H-3); 3.73-3.38 (m, 4H, H-4, H-5, H-6).  
13C NMR (62.9 MHz, CDCl3) δ =  156.3 (i-Ph); 129.7 (m-Ph); 122.4 (p-Ph); 116.0 (o-Ph); 
96.9 (C-1); 78.2 (C-5); 65.3 (C-4); 63.6 (C-3); 62.7 (C-2); 60.3 (C-6). 
C12H14N6O4(306.11):  
Calcd.: C, 47.06; H, 4.61; N, 27.44;  
Found: C, 46.78; H, 4.52; N, 27.27;  
4.4.12. Phenyl 4,6-O-diacetyl-2,3-diazido-2,3-dideoxy-β-D-mannopyranoside (43) 
    
OAcO
N3
N3AcO
OPh
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This compound was prepared from 42 (100 mg, 0.327 mmol) by a procedure similar to that 
used for the preparation of compound 38 (monitored by TLC: Tol-EtOAc 5:1). Purification by 
flash chromatography (eluent gradient EtOAc 0 → 20% in PE) provided compound 43 (119 
mg, 93.77 %) as colourless crystals. 
mp: 85-86°C; 
Rf: 0.37 (Tol-EtOAc 5:1); 
[α] 23D -83.3 ° (c 1.0, CHCl3);  
1H NMR (300.13 MHz, CDCl3) δ = 7.31 (m, 2H, m-Ph); 7.08 (m, 1H, p-Ph); 7.02 (m, 2H, p-
Ph); 5.25 (‘t’, 1H, 3J3,4 = 10.0 Hz, 3J4,5 = 9.8 Hz, H-4); 5.22 (d, 1H, 3J1,2 = 1.2 Hz, H-1); 4.27 
(dd, 1H, 2J = 12.3 Hz, 3J5,6a = 6.0 Hz, H-6a); 4.18 (dd, 1H, 3J2,3 = 3.5 Hz, 3J1,2 = 1.2 Hz, H-2); 
4.17 (dd, 1H, 2J= 12.3 Hz, 3J5,6b = 2.8 Hz, H-6b); 3.74 (ddd, 1H, 3J4,5 = 9.8 Hz, 3J5,6a = 6.0 Hz, 
3J5,6b = 2.8 Hz, H-5); 3.65 (dd, 1H, 3J3,4 = 10.0 Hz, 3J2,3 = 3.5 Hz, H-3); 2.14, 2.07 (2s, 6H, 
CH3CO).  
13C NMR (75.5 MHz, CDCl3) δ = 170.6, 169.3 (COCH3); 156.1 (i-Ph); 129.6 (m-Ph); 123.4 
(p-Ph); 116.6 (o-Ph); 98.1 (C-1); 73.3 (C-5); 66.7 (C-4); 62.7 (C-2); 62.3 (C-6); 61.6 (C-3); 
20.6, 20.6 (COCH3). 
C16H18N6O6(390.13): 
Calcd.: C, 49.23; H, 4.65; N, 21.53;  
Found: C, 49.55; H, 4.72; N, 21.89;  
 
4.4.13. Phenyl 2,3-diacetamido-2,3-dideoxy-β-D-mannopyranoside (37) 
    
OOH
AcNH
AcNHHO
OPh
 
To a solution of 40 (2g, 6.53 mmol) in methanol (20 mL) 10% palladium-on charcoal (ca. 
0.44 g) was added. The suspension was stirred for 5 h at room temperature under an 
atmosphere of hydrogen (monitored by TLC: ACN-Pyridine-Water 8:1:1).Then, the reaction 
mixture was filtered over Celite, eluted with MeOH and the combined filtrates were 
E X P E R I M E N T A L  S E C T I O N  
 62 
concentrated. Freshly distilled acetic anhydride (6.0 mL, 54.5 mmol ) was added at 0 °C to a 
stirred soln of the residue in dry pyridine (30 mL). After stirring for 2 h at that temperature 
(TLC: CHCl3-MeOH 10:1), the reaction mixture was poured into ice water (30 mL). The 
aqueous layer was extracted with DCM (3 x 20 mL). The combined extracts were washed 
successively with aq 15% NaHSO4 (3 x 25 mL), aq NaHCO3 (3 x 20 mL), water (20 mL), 
dried and concentrated. After drying under high vacuum for 3 h the residue was dissolved in 
dry methanol (20 mL) and sodium methoxide (0.5 M in methanol, 0.5 mL) was added. Afters 
stirring for 1 h at r.t., the reaction mixture was neutralised with IRC-120 (H+) resin, filtered, 
dried and concentrated. Flash Chromatography (eluent gradient Methanol 0 → 20% inCHCl3) 
gave compound 46 (0.74 g, 45 %) as colourless powder.  
Rf: 0.37 (CHCl3-MeOH 5:1); 
[α] 23D -106.3 ° (c 1.0, CHCl3: MeOH 1:1 v/v), 
1H NMR (500.13 MHz, DMSO-d6)  
δ = 7.64 (d, 1H, 3J3,NH = 8.2 Hz, NH(2); 7.43 (d, 1H, 3J2,NH = 9.77 Hz, NH(2)); 7.28 (m, 2H, o-
Ph); 6.96-1.01 (m, 4H, m-Ph, p-Ph); 5.38 (d, 1H, 3J1,2 = 1.58 Hz, H-1); 4.88 ( d, 1H, 3J4,OH 
=5.79 Hz, OH(4)); 4.45 (m, 1H, H-2); 4.35 (t, 1H, 3J6,OH = 5.04 Hz, OH(6));3.97 (ddd, 1H, 
3J2,3 = 3.97 Hz, 3J3,4 = 8.58 Hz, 3J3,NH = 9.77 Hz, H-3); 3.73 (ddd, 1H, 3J= 1.58, 3J5,6eq=3.78 
Hz, 3Jax,eq=12.25, H-6eq); 3.57 (d‘t’d, 1H, 3Jax,OH= 5.0, 3J5,6ax=7.55 Hz, 3Jax,eq=12.25, H-6ax); 
4.40-3.51 (m, 2H, H-4, H-5); 1.96, 1.79 (2S, 6H, 2 COCH3)  
13C NMR (125.8 MHz, DMSO-d6) δ = 170.02, 169.50 (COCH3); 156.5, 129.4, 121.87, 
116.21, (Ph); 79.0, 63.9 (C-4, C-5), 60.88 (C-6); 53.49 (C-3); 50.25 (C-2); 23.01, 22.71 
(COCH3) 
C16H22N2O6 (338.15) 
Calcd. :C, 56.80; H, 6.55; N, 8.28;  
Found: C, 56.21; H, 6.12; N, 7.59; 
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4.4.14. Methyl(phenyl 2,3-diazido-2,3-dideoxy-β-D-mannopyranoside)uronate (50) 
OHO
N3
N3H3CO
OPh
O
 
BAIB (bis(acetoxy)iodobenzene) (2.63 g, 8.17 mmol) was added to a mixture of 42 (1 g, 3.27 
mmol) and TEMPO (2,2,6,6-Tetramethylpiperidin-1-yl)oxyl) (102 mg, 0.65 mmol) in 30 mL 
DCM/H2O (ratio 3:1) at 0 ºC under stirring. The reaction was stirred for another 12 hours at 
RT (monitored by TLC: Tol-EtOAc-AA 16:4:1). 10 mL MeOH and further 25 mL 1 M 
Na2S2O3.5H2O was added slowly at 0 ºC. The layers were separated and the aqueous phase 
was acidified to PH 3 with 1M HCl and extracted with ethyl acetate. Then, the combined 
organic layer was dried with Na2SO4 and evaporated under vacuum. The crude product was 
taken directly to the next step with CH2N2 in MeOH. After completion of the reaction 
(monitored by TLC: Tol-EtOAc-AA 16:4:1), excess CH2N2 was quenched with acetic acid, 
the reaction mass was co-distilled with toluene and purified by column chromatography 
(eluent gradient EtOAc 0 → 40 % in PE) to provide 50(852mg, 79 %) as a colourless syrup. 
Rf: 0.3 (PE-EtOAc 1:1);  
[α] 24D -95.7 ° (c 1.0, CHCl3) 
1H NMR (300.13 MHz, DMSO-d6) δ = 7.34 (m, 2H, m-Ph); 7.05 (m, 1H, p-Ph); 7.03 (m, 2H, 
o-Ph); 6.14 (d, 1H, 3J4,OH = 6.5 Hz, OH); 5.70 (d, 1H, 3J1,2 = 1.3 Hz, H-1); 4.46 (dd, 1H, 3J2,3 = 
3.4 Hz, 3J1,2 = 1.3 Hz, H-2); 4.17 (d, 1H, 3J4,5 = 9.3 Hz, H-5); 3.87 (dd, 1H, 3J3,4 = 10.0 Hz, 
3J2,3 = 3.4 Hz, H-3); 3.78 (ddd, 1H, 3J3,4 = 10.0 Hz, 3J4,5 = 9.3 Hz, 3J4,OH = 6.5 Hz, H-4); 3.69 
(s, 3H, CH3CO).  
13C NMR (75.5 MHz, DMSO-d6) δ = 168.4 (COO); 155.8 (i-Ph); 129.8 (m-Ph); 122.8 (p-Ph); 
116.0 (o-Ph); 96.5 (C-1); 76.0 (C-5); 66.8 (C-4); 62.7 (C-3); 62.2 (C-2); 52.4 (OCH3). 
C13H14N6O5(334.29):  
Calcd.: C, 46.71; H, 4.22; N, 25.14;  
Found: C, 46.41; H, 4.13; N, 25.05;  
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4.4.15. Methyl(phenyl 2,3-diazido-4-O-benzoyl-2,3-dideoxy-β-D-
mannopyranoside)uronate (51) 
    
OBzO
N3
N3
OPh
OCH3O
 
In the course of 1 h benzoyl chloride (0.743 mL, 6.34 mmol) was added dropwise to a stirred 
soln of compound 50 (846 g, 2.52 mmol) in dry pyridine (9 mL) in  DCM(9 mL) at 0 °C. 
After stirring for 12 h at 0 °C (monitored by TLC: Tol-EtOAc 5:1). DCM (20 mL) was added 
to the reaction mass and the organic solution was washed with 15% cold NaHSO4 (3 X 10 
mL), aq NaHCO3 (3 x 10 mL), brine solution (15 mL) and concentrated. After repeated co-
distillation with toluene (3 x 10 mL) to remove pyridine the residue was purified by flash 
chromatography (Eluent Gradient: EtOAc 0 → 90% in PE) to provide 51 (965mg, 87 %) as 
colourless crystals. 
mp: 119-121°C; 
Rf: 0.54 (Tol-EtOAc 5:1); 
[α] 22D -119.8 ° (c 1.0, CHCl3); 
1H NMR (300.13 MHz, DMSO-d6) δ = 8.00 (m, 2H, o-Bz); 7.73 (m, 1H, p-Bz); 7.59 (m, 2H, 
m-Bz); 7.37 (m, 2H, m-Ph(1); 7.11-7.05 (m, 3H, o-Ph(1), p-Ph(1)); 5.81 (d, 1H, 3J1,2 = 1.3 Hz, 
H-1); 5.25 (dd, 1H, 3J3,4 = 10.2 Hz, 3J4,5 = 9.8 Hz, H-4); 4.76 (dd, 1H, 3J2,3 = 3.5 Hz, 3J1,2 = 1.3 
Hz, H-2); 4.69 (d, 1H, 3J4,5 = 9.8 Hz, H-5); 4.49 (dd, 1H, 3J3,4 = 10.2 Hz, 3J2,3 = 3.5 Hz, H-3); 
3.51 (s, 3H, OCH3). 13C NMR (75.5 MHz, DMSO-d6) δ = 167.3 (COOCH3); 165.1 (PhCOO); 
155.8 (i-Ph(1)); 134.3 (p-Bz); 129.9 (m-Ph(1)); 129.5 (o-Bz); 129.2 (m-Bz); 128.5 (i-Bz); 
123.0 (p-Ph(1)); 116.1 (o-Ph(1)); 96.3 (C-1); 72.2 (C-5); 68.1 (C-4); 61.9 (C-2); 60.5 (C-3); 
52.6 (OCH3). 
C20H18N6O6(438.39): 
Calcd.:C, 54.79; H, 4.14; N, 19.17;  
Found: C, 55.01; H, 4.25; N, 20.27; 
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4.4.16. Methyl(phenyl 2-azido-3-acetamido-4-benzoyl-2,3-dideoxy-β-D-
mannopyranoside)uronate (53) 
    
OBzO
AcNH
N3
OPh
OCH3O
 
Thioacetic acid (0.4 mL, 5.7 mmol) and 2,6-lutidine (0.66 mL, 5.7 mmol)was added to a 
solution of 51 (500 mg, 1.14 mmol)in dry 1,4-dioxane (12.5 mL)and stirred for 24 hours at 
100 °C(monitored by TLC, Tol-EtOAc 2:1). The reaction mass was filtered through a column 
of charcoal (packed over a layer of celite), concentrated and purified by column 
chromatography (Eluent Gradient: Ethyl acetate 0 → 50% in PE) providing 53 (362 mg, 70 
%) as colourless crystals. 
mp: 217-218°C;  
Rf: 0.26 (PE-EtOAc 1:1);  
[α] 22D -123.6 ° (c 1.04, CHCl3); 
1H NMR (300.13 MHz, DMSO-d6) δ = 8.32 (d, 1H, 3J3,NH = 9.0 Hz, NH); 7.88 (m, 2H, o-Bz);  
7.69 (m, 1H, p-Bz); 7.54 (m, 1H, m-Bz); 7.35 (m, 2H, m-Ph(1)); 7.09-7.03 (m, 3H, o-Ph(1), p-
Ph(1)); 5.99 (d, 1H, 3J1,2 = 1.3 Hz, H-1); 5.05 (dd, 1H, 3J3,4 = 10.4 Hz, 3J4,5 = 9.8 Hz, H-4); 
4.80 (ddd, 1H, 3J3,4 = 10.4 Hz, 3J3,NH = 9.0 Hz, 3J2,3 = 3.5 Hz, H-3); 4.65 (d, 1H, 3J4,5 = 9.8 Hz, 
H-5); 4.42 (dd, 1H, 3J2,3 = 3.5 Hz, 3J1,2 = 1.3 Hz, H-2); 3.50 (s, 3H, OCH3); 1.78 (s, 3H, 
CH3CO).  
13C NMR (75.5 MHz, DMSO-d6) δ = 169.9 (COCH3); 167.8 (COOCH3); 165.5 (PhCOO); 
155.8 (i-Ph(1)); 133.9 (p-Bz); 129.8 (m-Ph(1)); 129.3 (o-Bz); 129.1 (i-Bz); 129.0 (m-Bz); 
122.8 (p-Ph(1)); 116.1 (o-Ph(1)); 96.5 (C-1); 72.8 (C-5); 68.2 (C-4); 62.9 (C-2); 52.5 (OCH3); 
49.5 (C-3); 22.5 (COCH3). 
C22H22N4O7(454.43):   
Calcd.:C, 58.15; H, 4.88; N, 12.33;  
Found: C, 57.92; H, 4.79; N, 12.18;  
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4.4.17. Methyl(phenyl 2,3-diacetamido-4-O-benzoyl-2,3-dideoxy-β-D-
mannopyranoside)uronate (54) 
    
OBzO
AcNH
NHAc
OPh
OCH3O
 
To a solution of 53 (200 mg, 0.44 mmol) in EtOAc/MeOH 3:1 v/v mixture (4 mL), raney 
nickel (ca. 100 mg) and freshly distilled Ac2O (0.13mL, 1.359 mmol) was added and the 
suspension was stirred overnight at room temperature under an atmosphere of hydrogen 
(monitored by TLC: CHCl3-MeOH 20:1).The reaction mass was filtered through celite, 
concentrated and purification by column chromatography (MeOH 0→ 5% in CHCl3) 
provided 44 (172.5 mg, 83 %) as colourless foam. 
Rf: 0.3 (CHCl3-MeOH 20:1); 
[α] 22D -135.8° (c 1.04, CHCl3);  
1H NMR (300.13 MHz, DMSO-d6) δ = 8.08 (d, 1H, 3J2,NH = 9.8 Hz, NH(2)); 7.90 (m, 2H, o-
Bz); 7.79 (d, 1H, 3J3,NH = 9.1 Hz, NH(3)); 7.68 (m, 1H, p-Bz); 7.54 (m, 2H, m-Bz); 7.31 (m, 
2H, m-Ph(1)); 7.05-7.00 (m, 3H, o-Ph(1), p-Ph(1)); 5.79 (d, 1H, 3J1,2 = 2.0 Hz, H-1); 5.29 (dd, 
1H, 3J3,4 = 10.4 Hz, 3J4,5 = 9.5 Hz, H-4); 4.72 (ddd, 1H, 3J3,4 = 10.4 Hz, 3J3,NH = 9.1 Hz, 3J2,3 = 
4.1 Hz, H-3); 4.65 (d, 1H, 3J4,5 = 9.5 Hz, H-5); 4.60 (dd, 1H, 3J2,3 = 4.1 Hz, 3J1,2 = 2.0 Hz, 
3J2,NH = 9.8 Hz, H-2); 3.50 (s, 3H, OCH3); 2.02, 1.71 (2s, 6H, CH3CO).  
13C NMR (75.5 MHz, DMSO-d6) δ = 170.8, 169.7 (COCH3); 167.9 (COOCH3); 165.4 
(PhCOO); 156.2 (i-Ph); 133.7 (p-Bz); 129.7 (m-Ph(1)); 129.5 (i-Bz); 129.3 (o-Bz); 129.0 (m-
Bz); 122.5 (p-Ph(1)); 116.4 (o-Ph(1)); 96.3 (C-1); 72.8 (C-5); 68.3 (C-4); 52.3 (OCH3); 50.3 
(C-3); 50.0 (C-2); 23.1, 22.6 (COCH3). 
C24H26N2O8(470.47): 
Calcd.: C, 61.27; H, 5.57; N, 5.95;  
Found: C, 61.44; H, 5.45; N, 6.03; 
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4.4.18. Methyl(acetyl 2,3-diazido-4-O-benzoyl-2,3-dideoxy-β-D-
mannopyranoside)uronate (55) 
    
OBzO
N3
N3
OAc
OCH3O
 
Perchloric acid (70 %) (12.5 µL) was added to a solution of 51 (100 mg, 0.22 mmol) in 
freshly distilled acetic anhydride (1 mL) at 0 °C and stirred for 24 hours at that temperature. 
(monitored by TLC Tol-EtOAc10:1). The reaction mass was diluted with EtOAc (2mL) and 
washed with water (1 mL), NaHCO3 (3 x 1 mL), water (1 mL). Traces of acetic acid were 
removed by co-distillation with toluene. The crude product was concentrated and purified by 
column chromatography (Eluent Gradient: EtOAc 0 → 50% in PE) providing 55 (23 mg, 25 
%) as colourless glassy syrup. 
[α] 22D = + 35.9. (c 1.0, CHCl3); 
1H NMR (300.13 MHz, DMSO-d6) δ = 8.05 (m, 2H, o-Bz); 7.73 (m, 1H, p-Bz); 7.58 (m, 2H, 
m-Bz); 6.09 (d, 1H, 3J1,2 = 2.8 Hz, H-1); 5.33 (’t’, 1H, 3J3,4 = 9.2 Hz, 3J4,5 = 8.8 Hz, H-4); 4.70 
(dd, 1H, 3J3,4 = 9.2 Hz, 3J2,3 = 3.5 Hz, H-3); 4.59 (d, 1H, 3J4,5 = 8.8 Hz, H-5); 4.48 (dd, 1H, 
3J2,3 = 3.5 Hz, 3J1,2 = 2.8 Hz, H-2); 3.55 (s, 3H, OCH3); 2.17 (s, 3H, CH3CO).  
13C NMR (75.5 MHz, DMSO-d6) δ = 168.4 (COCH3); 167.4 (COOCH3); 165.0 (PhCOO); 
134.3 (p-Bz); 129.7 (o-Bz); 129.1 (m-Bz); 128.5 (i-Bz); 90.0 (C-1); 70.7 (C-5); 68.2 (C-4); 
60.2 (C-2); 59.2 (C-3); 52.6 (OCH3); 20.8 (COCH3). 
C16H16N6O7(404.33):  
Calcd. C, 47.53; H, 3.99; N, 20.78;  
Found C, 47.29; H, 3.63; N, 20.40;
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Appendix 
Crystal Data and Structural refinement 
Phenyl-2-O-triflyl-3-azido-3-deoxy-4-6-O-benzylidene-β-D-glucopyranoside (28) 
Identification code  is_e400colrc 
Empirical formula  C20H18F3N3O7S 
Formula weight  501.43 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  monoclinic 
Space group (H.-M.)  P 21 
Space group (Hall)  P 2yb 
Unit cell dimensions a = 10.6222(4) Å α = 90.00°. 
 b = 8.0316(3) Å β = 98.5100(10)°. 
 c = 13.0546Å γ = 90.00°. 
Volume 1101.47(7) Å3 
Z 2 
Density (calculated) 1.512 Mg/m3 
Absorption coefficient 0.220 mm-1 
F(000) 516 
Crystal size 0.99 x 0.22 x 0.12 mm3 
Θ range for data collection 1.94 to 30.99°. 
Index ranges -15≤h≤15, -10≤k≤11, -18≤l≤18 
 A P P E N D I X  
  
Reflections collected 14532 
Independent reflections 6277 [R(int) = 0.0186] 
Completeness to Θ = 30.99° 99.7%  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.8113 and 0.9740 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5636 / 0 / 307 
Goodness-of-fit on F2 1.046 
Final R indices [I>2σ(I)] R1 = 0.0335, wR2 = 0.0811 
R indices (all data) R1 = 0.0401, wR2 = 0.0854 
Largest diff. peak and hole 0.214 and -0.231 e.Å-3 
 
Phenyl-2-azido-2-deoxy-3-O-acetyl-4,6-O-benzylidene-β-D-altropyranoside (29) 
Identification code     e221colrc 
Empirical formula     C21H21N3O6 
Formula weight     411.41 
Temperature      173(2) K 
Wavelength   0.71073Å 
Crystal system      orthorhombic 
Space group (H.-M.)   'P 21 21 21' 
Space group (Hall)   'P 2ac 2ab' 
Unit cell dimensions  
 a = 9.9405(3)Å          α = 90.00°. 
 A P P E N D I X  
  
b = 13.2647(4)Å β = 90.00°. 
c = 15.3743(4)Å γ = 90.00 °.                  
Volume     2027.22(10) Å3 
Z 4 
Density (calculated)    1.348Mg/m3 
Absorption coefficient   0.100mm-1 
F(000)      864 
Crystal size 0.38 x 0.33 x 0.17 mm3 
Θ range for data collection 2.44to 30.00°. 
Index ranges -13≤h≤13, -18≤k≤17, -21≤l≤21 
Reflections collected 23088 
Independent reflections 5888 [R(int) = 0.0231] 
Completeness to Θ = 30.00° 99.9%  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9629and 0.9831 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5139 / 0 / 272 
Goodness-of-fit on F2 1.045 
Final R indices [I>2σ(I)] R1 = 0.0360, wR2 = 0.0911 
R indices (all data) R1 = 0.0450, wR2 = 0.0958 
Largest diff. peak and hole 0.249 and -0.231 e.Å-3 
 
 
 A P P E N D I X  
  
Phenyl-2-O-acetyl-3-azido-3-deoxy-4-6-O-benzylidene-β-D-glucopyranoside (30) 
Identification code  is_e222colrc 
Empirical formula  C21H21N3O6 
Formula weight  411.41 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  monoclinic 
Space group (H.-M.)     'P 21' 
Space group (Hall)  'P 2yb' 
Unit cell dimensions a = 8.2456(4)(4) Å α = 90.00°. 
 b = 5.6605(2) Å β = 90.134(2). 
 c = 21.8434(10) Å γ = 90.00°. 
Volume 1019.52(8) Å3 
Z 2 
Density (calculated) 1.340 Mg/m3 
Absorption coefficient 0.100 mm-1 
F(000) 432 
Crystal size 0.99 x 0.16 x 0.12 mm3 
Θ range for data collection 2.47to 29.96°. 
Index ranges -11≤h≤11, -7≤k≤5, -30≤l≤28 
Reflections collected 10243 
Independent reflections 4350 [R(int) = 0.0194] 
Completeness to Θ = 29.96° 98.5 %  
 A P P E N D I X  
  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9077and 0.9881 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters   3454/ 0 / 272 
Goodness-of-fit on F2    1.024 
Final R indices [I>2σ(I)] R1 = 0.0373, wR2 = 0.0805 
R indices (all data) R1 = 0.0526, wR2 = 0.0869 
Largest diff. peak and hole             0.264and -0.226 e.Å-3 
 
Phenyl-2,3-diazido-2,3-dideoxy-4,6-O-benzylideneβ-D-mannopyranoside (31) 
Identification code  is_e240col 
Empirical formula  C19H18N6O4 
Formula weight  394.39 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  monoclinic 
Space group (H.-M.)  P 21  
Space group (Hall)  P 2yb 
Unit cell dimensions a = 4.9198(2) Å α = 90.00°. 
 b = 9.8840(4) Å β = 90.529(2)°. 
 c = 19.0156(7) Å γ = 90.00°. 
Volume 924.64(6) Å3 
Z 2 
 A P P E N D I X  
  
Density (calculated) 1.417 Mg/m3 
Absorption coefficient 0.103 mm-1 
F(000) 412 
Crystal size 0.68 x 0.36 x 0.07 mm3 
Θ range for data collection 1.07 to 30.98°. 
Index ranges -6≤h≤7, -13≤k≤14, -27≤l≤27 
Reflections collected 11543 
Independent reflections 5694 [R(int) = 0.0196] 
Completeness to Θ = 30.98° 99.9%  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9331 and 0.9928 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4833 / 0 / 262 
Goodness-of-fit on F2 1.017 
Final R indices [I>2σ(I)] R1 = 0.0381, wR2 = 0.0951 
R indices (all data) R1 = 0.0495, wR2 = 0.1007 
Largest diff. peak and hole 0.297 and -0.210e.Å-3 
 
32 
Identification code  is_e269c1_2 
Empirical formula  C19H17N3O4 
Formula weight  351.36 
Temperature  173(2) K 
 A P P E N D I X  
  
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group (H.-M.)  P 1  
Space group (Hall)  P 1 
Unit cell dimensions a = 10.2247(5) Å α = 81.448(2)°. 
 b = 10.5323(5) Å β = 79.037(3)°. 
 c = 16.8949(8) Å γ = 75.623(2)°. 
Volume 1720.38(14) Å3 
Z 4 
Density (calculated) 1.357 Mg/m3 
Absorption coefficient 0.097 mm-1 
F(000) 736 
Crystal size 0.55 x 0.27 x 0.01 mm3 
Θ range for data collection 2.25 to 29.00°. 
Index ranges -13≤h≤13, -14≤k≤14, -23≤l≤21 
Reflections collected 43164 
Independent reflections 15585 [R(int) = 0.0265] 
Completeness to Θ = 29.00° 99.6%  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9099 and 0.9865 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 12409 / 0 / 207 
Goodness-of-fit on F2 1.006 
 A P P E N D I X  
  
Final R indices [I>2σ(I)] R1 = 0.0399, wR2 = 0.0828 
R indices (all data) R1 = 0.0589, wR2 = 0.0895 
Largest diff. peak and hole 0.143 and -0.214 e.Å-3 
Phenyl-2,3-diazido-2,3-dideoxy-β-D-mannopyranoside (33) 
Identification code  is_e306col 
Empirical formula  C16 H18 N6 O6 
Formula weight  390.36 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  monoclinic 
Space group (H.-M.)  P 21  
Space group (Hall)  P 2yb 
Unit cell dimensions a = 9.6731(14) Å α = 90.00°. 
 b = 5.2485(7) Å β = 103.678(7)°. 
 c = 18.712(3) Å γ = 90.00°. 
Volume 923.1(2) Å3 
Z 2 
Density (calculated) 1.404 Mg/m3 
Absorption coefficient 0.110 mm-1 
F(000) 408 
Crystal size 0.99 x 0.10 x 0.03 mm3 
Θ range for data collection 2.66 to 28.99°. 
Index ranges -13≤h≤13, -7≤k≤7, -25≤l≤25 
 A P P E N D I X  
  
Reflections collected 10831 
Independent reflections 4520 [R(int) = 0.0359] 
Completeness to Θ = 28.99° 99.9%  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission   0.8989 and 0.9967 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3609 / 0 / 255 
Goodness-of-fit on F2 1.014 
Final R indices [I>2σ(I)] R1 = 0.0402, wR2 = 0.0815 
R indices (all data) R1 = 0.0586, wR2 = 0.0886 
Largest diff. peak and hole 0.209 and -0.168 e.Å-3 
Methyl-(phenyl-2,3-diazido-2,3-dideoxy-4-benzoyl-β-D-mannopyranoside)uronate (42) 
Identification code   ch_OB2 
Empirical formula  C20 H18 N6 O6' 
Formula weight  438.40 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system     monoclinic 
Space group (H.-M.)     'P 21' 
Space group (Hall)  'P 2yb' 
Unit cell dimensions a = 13.2002(11)Å α= 90.00 (15)°. 
      b = 5.8944(6)Å        β= 91.944(6)°. 
 c = 26.554(3)Å γ = 90.00 (14)°. 
 A P P E N D I X  
  
Volume 2064.9(3)Å3 
Z 4 
Density (calculated) 1.410Mg/m3 
Absorption coefficient 0.107mm-1 
F(000) 912 
Crystal size 1.00 x 0.07 x 0.04 mm3 
Θ range for data collection 1.53 to 25.50°. 
Index ranges -15≤h≤15, -6≤k≤7, -32≤l≤32 
Reflections collected 16188 
Independent reflections 7396 [R(int) = 0.0547] 
Completeness to Θ = 25.50° 100 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission   0.9003 and 0.9957 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters   4921 / 0 / 579 
Goodness-of-fit on F2 1.000 
Final R indices [I>2σ(I)] R1 = 0.0486, wR2 = 0.0864 
R indices (all data) R1 = 0.0917, wR2 = 0.1037 
Largest diff. peak and hole   0.193 and -0.198e.Å-3
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